Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 11594. Отображено 100.
26-01-2012 дата публикации

High pressure balloon

Номер: US20120018090A1
Принадлежит: Boston Scientific Scimed Inc

Composite fiber reinforced balloons for medical devices are prepared by applying a web of fibers to the exterior of a preformed underlayer balloon, encasing the web with a matrix material to form an assembly, and inserting the assembly into a preformed outer layer balloon to form the composite balloon.

Подробнее
23-02-2012 дата публикации

Coating Comprising An Elastin-Based Copolymer

Номер: US20120046640A1
Принадлежит: Abbott Cardiovascular Systems Inc

The present invention is directed to medical devices including coatings. The coatings include a topcoat which includes a copolymer comprising a block of an elastin pentapeptide. The topcoat is over a layer of poly(vinyl alcohol) on a hydrophobic coating or over a porous coating comprising pores or depots that include a bioactive agent.

Подробнее
23-02-2012 дата публикации

Plasma modification of metal surfaces

Номер: US20120046735A1
Принадлежит: Intezyne Technologies Inc

The present invention provides modified metal surfaces, methods of preparing the same, and intermediates thereto. These materials are useful in a variety of applications including biomaterials.

Подробнее
01-03-2012 дата публикации

Balloon catheter devices with sheath covering

Номер: US20120053517A1
Принадлежит: Boston Scientific Scimed Inc

Catheter devices having an expandable balloon for delivering a therapeutic agent to a body site. In one aspect, one or more sheaths are disposed around the balloon with the therapeutic agent being disposed within the sheath, being disposed over the sheath, being contained in the space between the sheath and the balloon, or being otherwise associated with the sheath. In another aspect, the balloon includes a micro-electromechanical system (MEMS) for drug delivery.

Подробнее
22-03-2012 дата публикации

Reduced profile medical balloon element

Номер: US20120070599A1
Автор: Alan M. Zamore
Принадлежит: Individual

Medical dilatation balloons comprise a polymer that has the attribute of memory, and/or is crosslinked to impart memory. Such balloons exhibit a reduced tendency to overinflate at high inflation pressures. Furthermore, such balloons when shrunk radially by the application of heat while restraining axial shrinkage, exhibit customizable linear or non-linear compliance curves and lower crosslinking profile relative to the same balloon when unshrunk. Also disclosed is an expansive element within a tube whose outer diameter is equal to the outer diameter of the tube from which it was made. In addition, disclosed are (a) processes for preparing crosslinkable polymers, (b) joining crosslinked balloons to catheter systems, (c) forming shrunk balloon elements, and (d) forming an expansive element within a tube whose outer diameter is equal to the outer diameter of the tube from which it was made.

Подробнее
22-03-2012 дата публикации

Medical balloon having improved stability and strength

Номер: US20120071823A1
Автор: John J. Chen
Принадлежит: Boston Scientific Scimed Inc

A medical device, the medical device formed at least in part from a melt blend of at least one polymer comprising hydrolysable groups and a carbodiimide.

Подробнее
05-04-2012 дата публикации

Photochrome- or near ir dye-coupled polymeric matrices for medical articles

Номер: US20120082713A1
Принадлежит: Surmodics Inc

The invention provides polymers comprising pendent photochrome or near IR dye groups, as well as polymeric matrices made from these polymers, which can be used as or in association with a medical article. The polymers can be synthesized using methods that facilitate the preparation of medical articles having good biocompatibility. Exemplary polymeric matrices are in the form of lubricious coatings on medical devices, such as catheters. Visualization by irradiation of the photochrome or near IR dye can improve detection of the polymeric matrix on a device or in the body. This, in turn can improve aspects of a medical procedure, such as device insertion or matrix formation, as well as being useful for assessing the quality of the matrix.

Подробнее
10-05-2012 дата публикации

Bone marrow harvesting device having flexible needle

Номер: US20120116247A1
Принадлежит: Synthes USA LLC

A bone marrow harvesting device includes a flexible bone marrow harvesting needle that can bend during operation to prevent the needle tip from piercing the inner cortical wall of the target bone. The needle defines an aspiration channel that defines an intake end that is recessed to reduce the instances that the aspiration channel will be fouled by bone particles or other debris within the cancellous portion.

Подробнее
17-05-2012 дата публикации

Multilumen catheter with pressure resistant lumen and method

Номер: US20120123259A1
Автор: M. Samy Ahmed Hamboly
Принадлежит: Hamboly M Samy Ahmed

The assembly comprises two or more catheter tubes fused together to form a fused catheter bundle. Each tube has at least one lumen extending longitudinally through the catheter from its distal end to its proximal end and at least one of said tubes comprises a pressure resistant lumen. The tubes are fused together by use of heat & pressure generated by heat shrinkable tube slides positioned over a segment of the catheter tubes while mandrels are positioned within each tube lumen. After cooling, the heat shrinkable tube may be removed and the mandrels removed such that and the fused catheter bundle is formed. One or more of the tubes may be of a different hardness, material and/or color. A distal end of the fused catheter bundle can be split free floating, stepped or tapered tipped. A non fused portion may form catheter extension legs.

Подробнее
14-06-2012 дата публикации

Antimicrobial material and method for making the same

Номер: US20120150095A1
Автор: Michael Szycher
Принадлежит: Individual

This invention provides a modified catheter/indwelling device biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA) as an option, a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation. Alternatively, the sparsely soluble silver salt can be silver iodate and is combined with silver sulfadiazine. Chlorhexidine can also be included in the material.

Подробнее
14-06-2012 дата публикации

Drug Eluting Balloons with Ability for Double Treatment

Номер: US20120150142A1
Автор: Jan Weber, Jos Wetzels
Принадлежит: Boston Scientific Scimed Inc

In embodiments, medical devices, such as balloon catheters, can deliver a biologically active material to body tissue of a patient. The medical device includes a sponge delivery layer which can deliver multiple doses of one or more therapeutic agents to the body tissue. The medical device can further include a drug reservoir, which can supply the delivery layer with one or more therapeutic agents.

Подробнее
21-06-2012 дата публикации

Antimicrobial compounds having protective or therapeutic leaving groups

Номер: US20120157373A1
Принадлежит: MEDTRONIC INC

Antimicrobial compounds, such as silanol or alcohol, include a protecting or leaving group that can protect the compound from degradation during the process of preparing a medical device containing the compound or reduce the volatility of the compound relative to its counterpart without the leaving group. Nearly any hydrolysable leaving group may be employed. The leaving group may be an agent that may serve a therapeutic function in addition to protecting or retaining the antimicrobial agents.

Подробнее
05-07-2012 дата публикации

Implantable medical devices

Номер: US20120171354A1
Принадлежит: EnBIO Ltd

The present invention is directed to methods for producing a coated substrate, including dissolving at least one biomolecule to form a solution; nebulizing the solution to form a liquid aerosol; combining the liquid aerosol and a plasma to form a coating; and depositing, in the absence of reactive monomers, the coating onto a substrate surface. In an aspect, the substrate can be an implantable medical device.

Подробнее
05-07-2012 дата публикации

Hydrophilic polyurethane urea dispersions

Номер: US20120172519A1
Принадлежит: BAYER MATERIALSCIENCE AG

The invention relates to a polyurethane urea dispersion, wherein the polyurethane urea (1) is terminated with a copolymer unit of polyethylene oxide and poly-C4-C12-alkylene oxide, and (2) comprises at least one polycarbonate polyol containing hydroxyl groups.

Подробнее
05-07-2012 дата публикации

Progenitor endothelial cell capturing with a drug eluting implantable medical device

Номер: US20120172970A1
Принадлежит: Orbus Medical Technologies Inc

A medical device for implantation into vessels or luminal structures within the body is provided, which stimulates positive blood vessel remodeling. The medical device, such as a stent and a synthetic graft, is provided with a coating with a pharmaceutical composition containing a controlled-release matrix and one or more pharmaceutical substances for direct delivery of drugs to surrounding tissues. The coating on the medical device further comprises one or more barrier layers, and a ligand such as a peptide, an antibody or a small molecule for capturing progenitor endothelial cells in the blood contacting surface of the device for restoring an endothelium at the site of injury. In particular, the drug-coated stents are for use, for example, in balloon angioplasty procedures for preventing or inhibiting restenosis.

Подробнее
12-07-2012 дата публикации

Structural hydrogel polymer device

Номер: US20120178874A1
Автор: Scott M. Epstein
Принадлежит: Individual

The present invention relates generally a manufacturing process which results in a completely hydrogel polymer device that maintains lumen patency which allows for numerous applications. Catheters and stents are particular examples, and their composition, mechanical characteristics, and the significantly unique ability to conduct and allow fluids to pass from one end to the other without physiological rejection, inflammation, or manifestation of complications due to implant or otherwise undesirable outcomes when used for ambulatory and or therapeutic interventions is the purpose of the invention.

Подробнее
19-07-2012 дата публикации

Low viscosity liquid polymeric delivery system

Номер: US20120183629A1
Автор: Richard L. Dunn
Принадлежит: DUNN RES AND CONSULTING LLC

Low viscosity biodegradable polymer solutions of a liquid biodegradable polymer and biocompatible solvent and methods of using the compositions to form a biodegradable liquid polymer implant are provided.

Подробнее
19-07-2012 дата публикации

Polymer coating comprising 2- methoxyethyl acrylate units synthesized by surface-initiated atom transfer radical polymerization

Номер: US20120184029A1
Принадлежит: Danmarks Tekniskie Universitet

The present invention relates to preparation of a polymer coating comprising or consisting of polymer chains comprising or consisting of units of 2-methoxyethyl acrylate synthesized by Surface-Initiated Atom Transfer Radical Polymerization (SI ATRP) such as ARGET SI ATRP or AGET SI ATRP and uses of said polymer coating.

Подробнее
30-08-2012 дата публикации

Medical device employing liquid crystal block copolymers and method of making the same

Номер: US20120220932A1
Автор: John J. Chen
Принадлежит: Boston Scientific Scimed Inc

A medical device, at least a portion of which is formed from a polymer composition including at least one liquid crystal block copolymer having at least one A block and at least one B block wherein the A block is formed of mesogenic repeat units and the B block is a soft block.

Подробнее
13-09-2012 дата публикации

Medical device

Номер: US20120232527A1
Принадлежит: Boston Scientific Scimed Inc

A medical device including a shaft having an elongated inner member and an elongated tubular reinforcing member disposed over at least a portion of the inner member. In some embodiments, at least a portion of the outer surface of the inner member is spaced from the inner surface of the reinforcing member, defining a space substantially free of any other structures of the device. In some embodiments, the shaft can include a tip structure disposed on a distal portion of the inner member. In some such embodiments, the reinforcing member has a distal end, and the tip structure is disposed on the distal portion of the inner member adjacent the distal end of the reinforcing member. Additionally, in some embodiments, the reinforcing member can include a plurality of apertures defined therein, for example, to enhance the flexibility or other such characteristics of all or portions of the reinforcing member.

Подробнее
18-10-2012 дата публикации

Coating Comprising An Elastin-Based Copolymer

Номер: US20120263759A1
Принадлежит: Abbott Cardiovascular Systems Inc

A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided. The copolymer may be used as a coating on a stent. Methods of using a stent coated with the copolymer are also provided.

Подробнее
01-11-2012 дата публикации

Soluble coating comprising polyelectrolyte with hydrophobic counterions

Номер: US20120276185A1
Принадлежит: Individual

The present invention provides an implantable device having a biosoluble coating comprising a polyelectrolyte and a counterion and the methods of making and using the same.

Подробнее
06-12-2012 дата публикации

Use of bacterial polysaccharides for biofilm inhibition

Номер: US20120308632A1

A method comprises preventing or inhibiting bacterial adhesion and/or bacterial biofilm development by treating a substrate with a composition of a soluble group II capsular polysaccharide obtained from a bacterial strain.

Подробнее
06-12-2012 дата публикации

Localized delivery of drug agents

Номер: US20120310159A1
Автор: Charles D. Lennox
Принадлежит: Boston Scientific Scimed Inc

Medical devices including a substrate that are expandable from a compressed state to an expanded state; a coating on the substrate, the coating having a drug agent incorporated therein; and a sheath over the coating. The sheath is expandable from a compressed state to an expanded state and has at least one perforation therein. The medical devices are configured such that when the substrate is in a compressed state, the sheath is also in a compressed state and the perforation is substantially closed. When the substrate is in an expanded state, the sheath is also in an expanded state and the perforation is substantially open. The invention also includes a method of using the medical devices for the controlled, localized delivery of a drug agent to a target location within a mammalian body.

Подробнее
28-02-2013 дата публикации

Triple Balloon Occlusion and Infusion Catheter

Номер: US20130053758A1
Автор: Melina R. Kibbe
Принадлежит: Northwestern University

Disclosed are balloon catheters for forming liquid cast biodegradable arterial stents, typically, the balloon catheters include multiple balloons and multiple ports and include an element for promoting or initiating curing of a polymer solution via polymerization or cross-linking.

Подробнее
28-02-2013 дата публикации

Medical balloon and balloon catheter assembly

Номер: US20130053770A1
Принадлежит: Cook Medical Technologies LLC

A medical balloon ( 10 ) of a balloon catheter assembly ( 70 ) includes a balloon wall ( 22 ) formed of at least two layers ( 30, 32 ). The first layer ( 30 ) is made of an impervious polymeric material. The second layer ( 32 ), which is integral with the first layer ( 30 ) is made of a radiopaque and/or echogenic material and a polymeric material. In the preferred embodiment, there is provided 60 to 80% by weight of radiopaque material in the second layer ( 32 ). It has been found that these concentrations of radiopaque material provide good visibility of the balloon under ultrasonic imaging.

Подробнее
28-03-2013 дата публикации

Polyisobutylene-based polyurethanes

Номер: US20130079487A1
Принадлежит: Individual

An elastomeric polymer, comprising (1) a hard segment in the amount of 10% to 60% by weight of the elastomeric polymer, wherein the hard segment includes a urethane, urea or urethaneurea; and (2) a soft segment in the amount of 40% to 90% by weight of the elastomeric polymer. The soft segment comprises (a) at least 2% by weight of the soft segment of at least one polyether macrodiol, and/or at least one polycarbonate macrodiol; and (b) at least 2% by weight of the soft segment of at least one polyisobutylene macrodiol and/or diamine.

Подробнее
04-04-2013 дата публикации

Plasma-treated dialysis catheter cuff

Номер: US20130085451A1
Автор: Min-Shyan Sheu
Принадлежит: TYCO HEALTHCARE GROUP LP

A catheter is disclosed. The catheter includes an elongated tubular body defining a longitudinal axis and extending to a distal end thereof, the tubular body having at least one lumen and a cuff disposed around the tubular body configured to contact tissue, the cuff formed from a plasma-treated material having enhanced tissue ingrowth properties.

Подробнее
04-04-2013 дата публикации

Balloon for catheter and balloon catheter

Номер: US20130085519A1
Принадлежит: Terumo Corp

A balloon for catheter of the type that has a film body that is inflatable and deflatable by means of a fluid supplied from a catheter, the film body including a hard layer containing a polyamide and a flexible layer formed on the hard layer and containing a polyamide elastomer having a Shore D hardness that is not larger than 62, and the content of the amide units of the polyamide elastomer in the flexible layer is not less than 60 wt %

Подробнее
11-04-2013 дата публикации

Hydrophilic gels from polyurethane-based photoinitiators

Номер: US20130089582A1
Принадлежит: Coloplast AS

The present invention relates to the use of polymeric photoinitiators based on polyalkyletherurethane backbones in the production of hydrophilic gels, in particular hydrogels. The invention relates to methods for manufacturing hydrophilic gels using said polymeric photoinitiators, and the hydrophilic gels thus obtained.

Подробнее
09-05-2013 дата публикации

Medical device with bi-component polymer fiber sleeve

Номер: US20130116659A1
Автор: Stephen C. Porter
Принадлежит: Stryker Corp, Stryker NV Operations Ltd

An elongate medical device having a longitudinal axis and a surface; and a continuous, helical bi-component fiber wound around at least a portion of the surface of the medical device along its longitudinal axis, wherein the bi-component fiber has a cross-section with a generally flattened side and an inner core encased in a sheath, and wherein the inner core is aligned about the medical device.

Подробнее
16-05-2013 дата публикации

Balloon catheter coated with an anti-restenotic active ingredient and a molecular dispersion agent that promotes transport

Номер: US20130123695A1
Принадлежит: HEMOTEQ AG

The present invention relates to balloon catheters with or without crimped stent, whose surface is coated with at least one antirestenotic agent and at least one transport promoting molecular dispersant, as well as a method for the preparation of these medical devices.

Подробнее
23-05-2013 дата публикации

Medical devices having improved performance

Номер: US20130129793A1
Принадлежит: Boston Scientific Scimed Inc

In accordance with various aspects of the invention, implantable and insertable medical devices are provided, which contain one or more polymeric regions. In one aspect, the polymeric regions comprise (a) a block copolymer that comprises a polyaromatic block and a polyalkene block admixed with (b) a sulfonated high Tg polymer. In another aspect, the polymeric regions comprise a block copolymer that comprises (a) a sulfonated polymer block and (b) fluorinated polymer block.

Подробнее
23-05-2013 дата публикации

METHODS OF APPLYING A HYDROPHILIC COATING TO A SUBSTRATE, AND SUBSTRATES HAVING A HYDROPHILIC COATING

Номер: US20130131646A1
Автор: Gilman Thomas H.
Принадлежит: HOLLISTER INCORPORATED

This invention relates to methods of applying to a substrate a hydrophilic coating that becomes lubricious when activated with water or water vapor, and to substrates having such a hydrophilic coating. 1. A urinary catheter having a cross-linked hydrophilic coating disposed thereon , comprising:a catheter tube having an outer surface comprising a water-swellable polymer; anda cross-linked hydrophilic coating physically entangled with the water-swellable polymer of the outer surface of the catheter tube to sufficiently anchor the coating to the outer surface without the need for covalent interactions between the outer surface and the coating.2. The urinary catheter of wherein the catheter tube is made entirely of a water-swellable polymer.3. The urinary catheter of wherein the catheter tube includes an outer layer defining the outer surface of the catheter tube and the catheter tube includes an inner layer.4. The urinary catheter of wherein the inner layer is comprised of a non-water-swellable polymer.5. The urinary catheter of wherein the inner layer is comprised of a water-swellable polymer.6. The urinary catheter of wherein the outer surface also includes a non-water-swellable polymer.7. The urinary catheter of wherein the cross-linked hydrophilic coating comprises at least one of (i) a cross-linked water-soluble polymer and (ii) a polymerized water-soluble monomer.8. The urinary catheter of wherein the water-swellable polymer comprises a block copolymer selected from one or more of water-swellable polyamide-based copolymers claim 1 , water-swellable polyester-based copolymers claim 1 , water-swellable urethane-based copolymers.9. The urinary catheter of wherein the cross-linked water-soluble polymer is one or more of polyacrylic acids claim 7 , acrylic acid copolymers claim 7 , poly-N-vinyl lactams claim 7 , polyvinylalcohols claim 7 , polyvinylalcohol copolymers.10. A method of applying a hydrophilic coating to an outer surface of a catheter tube claim 7 , ...

Подробнее
23-05-2013 дата публикации

Fibrous matrix coating materials

Номер: US20130131765A1
Принадлежит: Cardiac Pacemakers Inc

A medical electrical lead may include an insulative lead body, a conductor disposed within the insulative lead body, an electrode disposed on the insulative lead body and in electrical contact with the conductor and a fibrous matrix disposed at least partially over the electrode. The fibrous matrix may be formed from a polyisobutylene urethane, urea or urethane/urea copolymer.

Подробнее
30-05-2013 дата публикации

Balloon Catheter

Номер: US20130138039A1
Автор: Yong Chul Ahn
Принадлежит: Individual

A balloon catheter is configured so that a balloon can be easily inserted into the interior of a human body without using a separate wire.

Подробнее
06-06-2013 дата публикации

Photo-vinyl linking agents

Номер: US20130143056A1
Принадлежит: Surmodics Inc

Embodiments of the invention include linking agents including photo groups and vinyl groups and coatings and devices that incorporate such linking agents, along with related methods. Exemplary methods herein include methods of priming substrates and methods of coating substrates using compounds having the formula R 1 —X—R 2 , wherein R 1 is a radical comprising a vinyl group, X is a radical comprising from about one to about twenty carbon atoms, and R 2 is a radical comprising a photoreactive group. Embodiments herein also include linking agents having the formula R 1 —X—R 2 , wherein R 1 is a radical comprising a vinyl group, X is a radical comprising from about one to about twenty carbon atoms, and R 2 is a radical comprising a photoreactive group. Other embodiments are also included herein.

Подробнее
13-06-2013 дата публикации

METHODS AND SYSTEMS FOR COATING A MEDICAL DEVICE

Номер: US20130150809A1
Принадлежит:

An antimicrobial coating system and method are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two of the cyclic groups may include quaternary ammonium moieties. In some embodiments, a method may include applying an antimicrobial coating to an oral surface, a surface of a construction substrate, a surface of a marine substrate, a surface of a medical device, or a surface of a personal care device. The protective coating may be antimicrobial. A protective coating may include antimicrobial bridged polycyclic compounds. Bridged polycyclic compounds may include quaternary ammonium compounds. Bridged polycyclic compounds based coating systems may impart self-cleaning properties to a surface (e.g., a tooth surface). 1323-. (canceled)324. A medical device coated with a coating , the coating comprising:a chemical composition, wherein at least a portion of the chemical composition forms an antimicrobial coating over at least a portion of a surface of a medical device, wherein the chemical composition comprises at least one bridged polycyclic compound, at least one of the bridged polycyclic compounds comprising at least two cyclic groups, and wherein at least one of the cyclic groups comprises a guanidinium moiety coupled to the cyclic group.326. The medical device of claim 325 , wherein the medical device comprises at least a portion of a catheter.327. The medical device of claim 325 , wherein the medical device comprises at least a portion of a contact lens.328. The medical device of claim 325 , wherein the medical device comprises at least a portion of a feeding tube.329. The medical device of claim 325 , wherein the medical device comprises at least a portion of a dental device or at least a portion of a dental fixture.331. The chemical composition of claim 330 , wherein at least one ...

Подробнее
20-06-2013 дата публикации

Luminal modifications for catheters

Номер: US20130158488A1
Принадлежит: Semprus Biosciences Corp

Catheters and a method of preparation thereof comprising a catheter body and at least one connector. The catheter body has an exterior surface and at least one lumen having an aspect ratio of at least 3:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer has an average dry thickness of at least about 50 nanometers.

Подробнее
27-06-2013 дата публикации

Balloon catheter tapered shaft having high strength and flexibility and method of making same

Номер: US20130160932A1
Принадлежит: Abbott Cardiovascular Systems Inc

Method of making a balloon catheter includes melt-extruding a thermoplastic polymeric material into a tube, cooling the extruded tube, placing the extruded tube within a capture member and biaxially orienting the polymeric material of the extruded tube while simultaneously tapering at least a section of the extruded tube by radially expanding the extruded tube with pressurized media in the tube lumen and axially expanding the extruded tube with an external load applied on at least one end of the tube as an external heat supply traverses longitudinally from a first end to a second end of the extruded tube in the capture member, wherein an overall axial load on the tubing is varied as at least a section of the tube is heated. The method includes cooling the expanded tube to form a tapered biaxially oriented nonporous thermoplastic polymer tubular member and sealingly securing a balloon proximate a distal end of the tubular member.

Подробнее
04-07-2013 дата публикации

Stimuli Responsive Nanofibers

Номер: US20130171331A1
Принадлежит: Individual

A stimuli responsive nanofiber that includes a stimuli responsive polymer, such as a thermally responsive polymer, and a cross-linking agent having at least two latent reactive activatable groups. The nanofiber may also include a biologically active material or a functional polymer. The stimuli responsive nanofiber can be used to modify the surface of a substrate. When the nanofiber includes a thermally responsive polymer, the physical properties of the surface can be controlled by controlling the temperature of the system, thus controlling the ability of the surface to bind to a biologically active material of interest.

Подробнее
04-07-2013 дата публикации

Non-compliant multilayered balloon for a catheter

Номер: US20130172817A1
Автор: Jonathan P. Durcan
Принадлежит: Abbott Cardiovascular Systems Inc

Balloon catheter comprises an elongate catheter shaft having a proximal section, a distal section, and an inflation lumen, and a multilayer balloon on the distal section of the shaft. The multilayer balloon comprises at least a first layer and a second layer having a combined wall thickness and an outer-most layer. The first layer is made of a first polymer material having a first maximum blow-up-ratio. The second layer is made of a second polymer material having a second maximum blow-up-ratio greater than the first maximum blow-up-ratio and the second layer is an inner layer relative to the first layer. The at least first and second layers define a compliance less than that of a single layer balloon made of the first polymer material with a wall thickness equal to the combined wall thickness. The outer-most layer is made of a third polymer material.

Подробнее
18-07-2013 дата публикации

Lubricious extruded medical tubing

Номер: US20130184659A1
Принадлежит: Contech Medical Inc

A medical tube having improved lubricity is disclosed. The medical tube is produced by extruding a polymer material blended with a lubricity enhancing additive through a resilient die. The polymer material can be medical-grade high-density polyethylene, and the lubricity enhancing additive can be a silicone-based or alloy-based material. The medical tube can include one or more internal elongated protuberances so as to reduce the internal surface area of the medical tube available to generate friction on a guide wire inserted or withdrawn through the medical tube.

Подробнее
25-07-2013 дата публикации

Polyurethane-polyethylene delamination resistant tubing with gas barrier properties

Номер: US20130190723A1
Принадлежит: Tekni Plex Inc

A tube comprising an inner layer, an outer layer and a barrier layer disposed between the inner layer and the outer layer, wherein the barrier layer is bound to the outer layer by a layer of adhesive disposed between the outer layer and the barrier layer and the barrier layer is bound to the inner layer by a layer of adhesive disposed between the inner layer and the barrier layer, wherein the inner layer comprises a polyethylene, the outer layer comprises a thermoplastic polyurethane and the barrier layer comprises a material that acts as a barrier to gas.

Подробнее
01-08-2013 дата публикации

DRUG RELEASING COATINGS FOR MEDICAL DEVICES

Номер: US20130197431A1
Автор: Wang Lixiao
Принадлежит: Lutonix, Inc.

The invention relates to a medical device for delivering a therapeutic agent to a tissue. The medical device has a layer overlying the exterior surface of the medical device. The layer contains a therapeutic agent, an antioxidant, and an additive. In certain embodiments, the additive has a hydrophilic part and a drug affinity part, wherein the drug affinity part is at least one of a hydrophobic part, a part that has an affinity to the therapeutic agent by hydrogen bonding, and a part that has an affinity to the therapeutic agent by van der Waals interactions. In some embodiments, the additive is a liquid. In other embodiments, the additive is at least one of a surfactant and a chemical compound, and the chemical compound has one or more hydroxyl, amino, carbonyl, carboxyl, acid, amide or ester groups. 1. A medical device for delivering a therapeutic agent to a tissue , the device comprising a layer overlying an exterior surface of the medical device , the layer comprising a therapeutic agent , an antioxidant and an additive , wherein:the antioxidant is selected from at least one of butylated hydroxytoluene and butylated hydroxyanisole;the additive comprises a hydrophilic part and a drug affinity part;the drug affinity part is at least one of a hydrophobic part, a part that has an affinity to the therapeutic agent by hydrogen bonding, and a part that has an affinity to the therapeutic agent by van der Waals interactions;the additive is water-soluble;the additive is at least one of a surfactant and a chemical compound; andthe chemical compound has one or more hydroxyl, amino, carbonyl, carboxyl, acid, amide or ester groups.2. The medical device according to claim 1 , wherein the chemical compound is chosen from amino alcohols claim 1 , hydroxylcarboxylic acid claim 1 , ester claim 1 , amides claim 1 , ethers claim 1 , anhydrides claim 1 , hydroxyl ketone claim 1 , hydroxyl lactone claim 1 , hydroxyl ester claim 1 , sugar phosphate claim 1 , sugar sulfate claim 1 , ...

Подробнее
01-08-2013 дата публикации

LUBRICIOUS MEDICAL DEVICE COATING WITH LOW PARTICULATES

Номер: US20130197433A1
Автор: Babcock David E.
Принадлежит: SURMODICS, INC.

Embodiments of the invention include lubricious medical device coatings. In an embodiment the invention includes a coating for a medical device including a first layer comprising polyvinylpyrrolidone derivatized with a photoreactive group; and a first cross-linking agent comprising at least two photoreactive groups; a second layer disposed on the first layer comprising polyvinylpyrrolidone derivatized with a photoreactive group; a second cross-linking agent comprising at least two photoreactive groups; and a polymer comprising polyacrylamide, the polymer derivatized with at least one photoreactive group. Other embodiments are included herein. 1. A coating for a medical device comprising: polyvinylpyrrolidone derivatized with a photoreactive group; and', 'a first cross-linking agent comprising at least two photoreactive groups;, 'a first layer comprising'} polyvinylpyrrolidone derivatized with a photoreactive group;', 'a second cross-linking agent comprising at least two photoreactive groups; and', 'a polymer comprising polyacrylamide, the polymer derivatized with at least one photoreactive group., 'a second layer disposed on the first layer comprising'}2. (canceled)3. (canceled)4. The coating of claim 1 , the polymer comprising polyacrylamide in the second layer comprising a polymer comprising polyacrylamide claim 1 , 2-acrylamido-2-methylpropanesulfonate (AMPS) claim 1 , and polyethyleneglycol subunits.5. The coating of claim 1 , the polymer comprising polyacrylamide in the second layer comprising N-Acetylated poly[acrylamide-co-sodium-2-acrylamido-2-methylpropanesulfonate-co-N-(3-(4-benzoylbenzamido)propyl)methacrylamide]-co-methoxy poly(ethylene glycol)monomethacrylate.6. The coating of claim 1 , wherein the ratio of polyvinylpyrrolidone derivatized with a photo reactive group in the second layer to the polymer comprising polyacrylamide in the second layer is between approximately 3:1 and 1:3 (wt./wt.).7. (canceled)8. The coating of claim 1 , wherein the ratio of ...

Подробнее
01-08-2013 дата публикации

DRUG RELEASING COATINGS FOR BALLOON CATHETERS

Номер: US20130197434A1
Автор: Wang Lixiao
Принадлежит: Lutonix, Inc.

Balloon catheters, methods for preparing balloon catheters, and uses of balloon catheters are disclosed. The balloon catheter includes an elongate member, an expandable balloon, and a coating layer overlying an exterior surface of the expandable balloon. The coating layer includes a total drug load of a hydrophobic therapeutic agent and a combination of additives including a first additive and a second additive. The hydrophobic therapeutic agent is paclitaxel, rapamycin, or paclitaxel and rapamycin. The first additive is a surfactant. The second additive is a chemical compound having one or more hydroxyl, amino, carbonyl, carboxyl, acid, amide, or ester groups. 2. The balloon catheter of claim 1 , wherein the hydrophobic therapeutic agent is paclitaxel.3. The balloon catheter of claim 1 , wherein the hydrophobic therapeutic agent is rapamycin.4. The balloon catheter of claim 1 , wherein the hydrophobic therapeutic agent is uniformly distributed in the coating layer.5. The balloon catheter of claim 1 , wherein the total drug load of the hydrophobic therapeutic agent is from 1 μg to 20 μg per square millimeter of the expandable balloon.6. The balloon catheter of claim 1 , wherein the total drug load of the hydrophobic therapeutic agent is from 2.5 μg to 6 μg per square millimeter of the expandable balloon.7. The balloon catheter of claim 1 , wherein the first additive is a PEG sorbitan monolaurate.8. The balloon catheter of claim 7 , wherein the PEG sorbitan monolaurate is PEG-20 sorbitan monolaurate.9. The balloon catheter of claim 1 , wherein the first additive is a PEG sorbitan monooleate.10. The balloon catheter of claim 9 , wherein the PEG sorbitan monooleate is PEG-20 sorbitan monooleate.11. The balloon catheter of claim 1 , wherein the first additive is one of PEG-20 sorbitan monolaurate claim 1 , PEG-20 sorbitan monooleate claim 1 , or combinations thereof.12. The balloon catheter of claim 1 , wherein the second additive is one of sorbitol claim 1 , ...

Подробнее
29-08-2013 дата публикации

COMPOSITIONS AND METHODS FOR COATING MEDICAL IMPLANTS

Номер: US20130224276A1
Принадлежит: Angiotech International AG

Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or reducing the incidence of infection associated with the implant. 112-. (canceled)13. A composition , comprising a polymer and a fluoropyrimidine , wherein said fluoropyrimidine is present in said composition at a concentration of less than 10M.14. The composition according to wherein said fluoropyrimidine is present in said composition at a concentration of less than any one of 10M claim 13 , 10M claim 13 , or 10M.15. The composition according to wherein said polymer is a non-biodegradable polymer.16. The composition according to wherein said polymer is a polyurethane.17. The composition according to wherein said polymer is a poly(lactide-co-glycolide).18. The composition according to wherein said fluoropyrimidine is 5-fluorouracil.19. A method for reducing or inhibiting infection associated with a medical implant claim 13 , comprising the step of introducing into a patient a medical implant which has been covered or coated with a fluoropyrimidine.20. The method according to wherein said fluoropyrimidine is 5-fluorouracil.21. A method for making medical implants claim 19 , comprising covering or coating a medical implant with a fluoropyrimidine.22. The method according to wherein said fluoropyrimidine is 5-fluorouracil.23. The method according to wherein said medical implant covered or coated by dipping or by impregnation. This application is a continuation of U.S. patent application Ser. No. 11/343,714, filed Jan. 31, 2006, which is a continuation of U.S. patent application Ser. No. 10/447,309, filed May 27, 2003, now abandoned, which claims benefit under 35 U.S.C. §119(e) of U.S. Provisional Application Ser. No. 60/383,419, filed May 24, 2002, which applications are incorporated herein by reference in their entirety.1. Field of the InventionThe present invention relates ...

Подробнее
19-09-2013 дата публикации

Bioabsorbable Polymeric Compositions and Medical Devices

Номер: US20130245206A1
Принадлежит: ORBUSNEICH MEDICAL, INC.

The bioabsorbable polymers and compositions of the present invention may be formed into medical devices such as stents that can be crimped onto a catheter system for delivery into a blood vessel. The properties of the bioabsorbable polymers allow for both crimping and expansion of the stent. The crystal properties of the bioabsorbable polymers may change during crimping and/or expansion allowing for improved mechanical properties such as tensile strength and slower degradation kinetics. Typically, bioabsorbable polymers comprise aliphatic polyesters based on lactide backbone such as poly L-lactide, poly D-lactide, poly D,L-lactide, mesolactide, glycolides, lactones, as homopolymers or copolymers, as well as formed in copolymer moieties with co-monomers such as, trimethylene carbonate (TMC) or ε-caprolactone (ECL). 1. A composition comprising a blend formed from poly-L-lactide , poly-D-lactide or mixtures thereof and a copolymer moiety comprising poly-L-lactide or poly-D-lactide linked with β-caprolactone or trimethylcarbonate wherein , the poly-L-lactide or poly-D-lactide sequence in the copolymer moiety is random with respect to the distribution of ε-caprolactone or trimethylcarbonate and where the wide-angle X-ray scattering (WAXS) exhibits 20 values of about 16.48 and about 18.76.2. The composition of wherein the co-polymer moiety comprises poly-L-lactide or poly-D-lactide linked with ε-caprolactone.3. The composition of wherein the polymer moiety comprises poly-L-lactide.4. The composition of wherein the polymer moiety comprises poly-D-lactide.5. The composition of wherein the co-polymer moiety is poly-L-lactide or poly-D-lactide linked with TMC and the molecular weight of the co-polymer ranges from about 1.2 IV to about 2.6 IV.6. The composition of wherein the molecular weight of the co-polymer ranges from about 0.8 to about 6.0.7. The composition of wherein the WAXS 2θ values further comprise peaks at about 11.92 claim 1 , about 20.66 claim 1 , about 22.24 and ...

Подробнее
03-10-2013 дата публикации

RAPAMYCIN COATED EXPANDABLE DEVICES

Номер: US20130261602A1
Принадлежит:

Medical devices may be utilized for local and regional therapeutic agent delivery. These therapeutic agents or compounds may reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including restenosis, vulnerable plaque, and atherosclerosis in type 2 diabetic patients. 1. A medical device comprising:an expandable member having a first diameter for insertion into a vessel and a second diameter for making contact with the vessel walls; and{'sup': '2', 'a liquid formulation of a rapamycin affixed to at least a portion of the surface of the expandable member, the liquid formulation of a rapamycin comprising about 50 mg/ml of sirolimus and at least about 2.5 mg/ml BHT combined in a solvent system of isopropanol/water in a ratio of 3.4/1 by volume, the liquid formulation of a rapamycin affixed to the expandable member having a surface density of sirolimus of up to about 7 μg/mmwhen dried on the surface of the expandable member.'}2. The medical device according to claim 1 , wherein the expandable member comprises a balloon.3. The medical device according to claim 2 , further comprising a stent positioned over the balloon.4. A liquid formulation of a rapamycin comprising about 50 mg/ml of sirolimus and at least about 2.5 mg/ml BHT combined in a solvent system of isopropanol/water in a ratio of 3.4/1 by volume.5. A method for the treatment of vascular disease comprising:positioning an expandable member having a first unexpanded diameter proximate a treatment site of a diseased vessel; and{'sup': '2', 'expanding the expandable member to a second diameter such that it makes contact with the vessel walls at the treatment site, the expandable member having a coating comprising about 50 mg/ml of sirolimus and at ...

Подробнее
03-10-2013 дата публикации

TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS

Номер: US20130261603A1
Автор: Wang Lixiao
Принадлежит: Lutonix, Inc.

Embodiments of the present invention provide a method for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, and chronic sinusitis, including cystic fibrosis, interstitial fibrosis, chronic bronchitis, emphysema, bronchopulmonary dysplasia and neoplasia. The method involves administration, preferably oral, nasal or pulmonary administration, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues) and an additive. 156-. (canceled)57. A device sized and configured for insertion into a passage of a respiratory system , the device comprising a layer overlying an exterior surface of the device , the layer comprising a water insoluble drug for the treatment of the respiratory system and an additive that enhances absorption of the drug into tissue of the respiratory system , wherein:the device is a balloon catheter;the water insoluble drug is chosen from paclitaxel and rapamycin; andthe additive is at least one of a surfactant and a chemical compound, wherein the chemical compound is chosen from amino alcohols, hydroxyl carboxylic acid, ester, anhydrides, hydroxyl ketone, hydroxyl lactone, hydroxyl ester, sugar phosphate, sugar sulfate, ethyl oxide, ethyl glycols, amino acids, peptides, proteins, sorbitan, glycerol, polyalcohol, phosphates, sulfates, organic acids, esters, salts, vitamins, combinations of amino alcohol and organic acid, and their substituted molecules.5862-. (canceled)63. The device according to claim 57 , wherein the surfactant is chosen from ionic claim 57 , nonionic claim 57 , aliphatic claim 57 , and aromatic surfactants claim 57 , PEG fatty esters claim 57 , PEG omega-3 fatty esters claim 57 , ether claim 57 , and alcohols claim 57 , glycerol fatty esters claim 57 , sorbitan fatty esters claim 57 , PEG glyceryl fatty esters claim 57 , PEG sorbitan fatty esters claim 57 , sugar fatty esters claim 57 , PEG sugar esters claim 57 , and derivatives thereof.64. The device ...

Подробнее
24-10-2013 дата публикации

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

Номер: US20130280410A1
Принадлежит: COVIDIEN LP

A method and device for local delivery of a water-insoluble therapeutic agent to the tissue of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with a non-durable coating which comprises poly(HEMA) complexed with iodine and has a substantially water-insoluble therapeutic agent dispersed therein. The medical disposable device is inserted into a body lumen, and expanded to contact the non-durable coating against the body lumen and deliver the substantially water-insoluble therapeutic agent to the body lumen tissue.

Подробнее
31-10-2013 дата публикации

Rod shaped body and medical device

Номер: US20130289533A1
Принадлежит: MaRVis Tech GmbH

The present invention relates to a medical device. In particular, the present invention concerns a medical device which can be detected by means of magnetic resonance imaging (MRI).

Подробнее
14-11-2013 дата публикации

COATED MEDICAL DEVICES INCLUDING A WATER-INSOLUBLE THERAPEUTIC AGENT

Номер: US20130303983A1
Принадлежит:

A medical device includes an implantable structure and a coating layer including a water-insoluble therapeutic agent and one or more additives selected from heparin, heparan sulfate, dextran and dextran sulfate, and physiologically-acceptable salts thereof. The one or more additives can be present in an amount effective to increase the rate of release of the water-insoluble therapeutic agent from the coating layer. The implantable medical device structure can be an expandable structure such as a balloon or stent. Also described are methods of making and using such implantable medical devices and coating layers. 1. A medical device , comprising:an implantable medical device structure having a surface; and (i) a water-insoluble therapeutic agent; and', '(ii) one or more additives selected from heparin, heparan sulfate, dextran, and dextran sulfate; and physiologically-acceptable salts thereof., 'a coating layer carried by the surface and including2. The medical device of claim 1 , wherein the implantable medical device structure is an expandable structure.3. The medical device of claim 2 , wherein the expandable structure is a balloon.4. The medical device of claim 3 , wherein the balloon is an angioplasty balloon.5. The medical device of claim 3 , wherein the balloon has a balloon wall in a folded condition.6. The medical device of claim 2 , wherein the expandable structure is a stent.7. The medical device of claim 1 , wherein the water-insoluble therapeutic agent is an immunosuppressive agent claim 1 , an antiproliferative agent claim 1 , a microtubule stabilizing agent claim 1 , a restenosis-inhibiting agent claim 1 , or an inhibitor of the mammalian target of rapamycin.8. The medical device of claim 1 , wherein the water-insoluble therapeutic agent is a taxane compound.9. The medical device of claim 8 , wherein the taxane compound is paclitaxel.10. The medical device of claim 1 , wherein the therapeutic agent is a macrolide immunosuppressive agent.11. The medical ...

Подробнее
14-11-2013 дата публикации

Loading and release of water-insoluble drugs

Номер: US20130304029A1
Принадлежит: Boston Scientific Scimed Inc

A medical device, polymer composition, and method for delivering substantially water-insoluble drugs to tissue at desired locations within the body. At least a portion of the exterior surface of the medical device is provided with a polymer coating. Incorporated in the polymer coating is a solution of at least one substantially water-insoluble drug in a volatile organic solvent. The medical device is positioned to a desired target location within the body, whereupon the drug diffuses out of the polymer coating.

Подробнее
28-11-2013 дата публикации

LOW-MODULUS ELASTOMERIC COMPOSITIONS AND ARTICLES MADE THEREWITH

Номер: US20130316107A1
Принадлежит: CHURCH & DWIGHT CO., INC.

The present invention provides an elastomeric composition for making elastomeric articles having at least one layer, such as but not limited to condoms, which have a deformation stress or modulus below about 1.5 MPa at 500% extension, comprising at least one polymeric material, at least one plasticizer and optionally at least one coating. The elastomeric articles also have unique tactile and tensile properties, such as conformability and low radius of curvature. 1. An elastomeric article having at least one layer , said at least one layer comprising at least one styrenic block copolymer and at least one plasticizer , wherein said article has a modulus of less than 1.5 MPa at 500% extension.2. The elastomeric article of claim 1 , wherein said article has a modulus of less than 1.2 MPa at 500% extension.3. The elastomeric article of claim 2 , wherein said article has a modulus of less than 1.0 MPa at 500% extension.4. The elastomeric article of claim 1 , wherein said styrenic block copolymer is selected from SEBS (styrene-block-ethylene-co-butylene-block-styrene) claim 1 , SEPS (styrene-block-ethylene-co-propylene-block-styrene) claim 1 , SEEPS (styrene-block-ethylene-co-ethylene-propylene-block-styrene) claim 1 , SEEPS (styrene-block-ethylene-co-ethylene-butylene-block-styrene) claim 1 , SBS (styrene-block-butadiene-block-styrene) claim 1 , SIS (styrene-block-isoprene-block-styrene) and the mixtures thereof.5. The elastomeric article of claim 1 , wherein said styrenic block copolymer is in star form claim 1 , or a blend of star and linear styrenic block copolymers.6. The elastomeric article of claim 1 , wherein said styrenic block copolymer is blended with rubber latex (NRL) claim 1 , synthetic polyisoprene (PI) claim 1 , polyurethane (PU) claim 1 , silicone claim 1 , styrene-co-butadiene (SB) claim 1 , or styrene-co-isoprene (SI).7. The elastomeric article of claim 4 , wherein said styrenic block copolymer is a blend of SEBS with SEPS claim 4 , and/or SEEPS.8. The ...

Подробнее
28-11-2013 дата публикации

Drug eluting medical implant

Номер: US20130317600A1
Принадлежит: Individual

Disclosed are self-expanding medical implants for placement within a lumen of a patient. The implants comprise a woven or non-woven structure having a substantially tubular configuration, and are designed to be low-profile such that they are deliverable with a small diameter catheter. The implants have a high recoverability and desired mechanical properties.

Подробнее
05-12-2013 дата публикации

Stents With Radiopaque Markers

Номер: US20130325106A1
Автор: Patrick P. Wu
Принадлежит: Abbott Cardiovascular Systems Inc

Various embodiments of stents with radiopaque markers arranged in patterns are described herein.

Подробнее
19-12-2013 дата публикации

Medical Devices and Implements with Liquid-Impregnated Surfaces

Номер: US20130337027A1
Принадлежит: Massachusetts Institute of Technology

Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces between said solid features, the surface stably contains the impregnating liquid between the solid features, and the impregnating liquid is substantially held in place between the plurality of solid features regardless of orientation of the surface.

Подробнее
19-12-2013 дата публикации

APPARATUS AND METHODS FOR COATING MEDICAL DEVICES

Номер: US20130337147A1
Принадлежит:

Embodiments of the invention include apparatus and methods for coating drug eluting medical devices. In an embodiment, the invention includes a coating apparatus including a coating application unit comprising a movement restriction structure; a fluid applicator; and an air nozzle. The apparatus can further include a rotation mechanism and an axial motion mechanism, the axial motion mechanism configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another. Other embodiments are also included herein. 1. A coating apparatus comprising: a movement restriction structure;', 'a fluid applicator;', 'an air nozzle; and, 'a coating application unit comprising'}a rotation mechanism; andan axial motion mechanism, the axial motion mechanism configured to cause movement of at least one of the coating application unit and the rotation mechanism with respect to one another.2. (canceled)3. (canceled)4. (canceled)5. The coating apparatus of claim 1 , further comprising a fluid reservoir in fluid communication with the fluid applicator;6. The coating apparatus of claim 1 , further comprising a fluid pump in fluid communication with the fluid reservoir and the fluid applicator.7. (canceled)8. (canceled)9. The coating apparatus of claim 1 , the fluid applicator comprising a shaft including a curved portion and an orifice claim 1 , wherein the curved portion of the shaft is disposed between the orifice and the distal end of the shaft.10. (canceled)11. The coating apparatus of claim 1 , the coating application unit further comprising a fluid distribution bar.12. The coating apparatus of claim 1 , wherein the movement restriction structure prevents lateral movement of the drug eluting balloon catheter as it is being rotated by the rotation mechanism.13. The coating apparatus of claim 1 , the movement restriction structure defining a channel surrounding the drug eluting balloon catheter.14. The coating apparatus of claim 1 ...

Подробнее
26-12-2013 дата публикации

COATING AND COATING METHOD FOR THE BALLOON OF A BALLOON CATHETER, AND BALLOON CATHETER WITH COATED BALLOON

Номер: US20130345629A1
Автор: Rübben Alexander
Принадлежит:

The invention relates to an active-substance-containing coating for the balloon of a balloon catheter, to a balloon of a balloon catheter with the coating, and to a balloon catheter with such a balloon. The invention further relates to the use of the coating for a balloon of a balloon catheter, and to a method for coating an active-substance-coated balloon and for producing an agent for modifying the release of an active substance applied to a surface of the balloon of a balloon catheter. A coating for a balloon of a balloon catheter is proposed which comprises at least one lipophilic active substance and an agent for modifying the release of active substance to a vessel that surrounds the balloon, wherein the agent for modifying the release of active substance is a polysaccharide having a molecular mass of 10,000 Da to 100,000,000 Da. 115-. (canceled)17. Balloon according to claim 16 , wherein the polysaccharide is a natural polysaccharide or a modified polysaccharide or a mixture of various of these polysaccharides.18. Balloon according to claim 17 , wherein the polysaccharide is a natural dextran.19. Balloon according to claim 18 , wherein the natural dextran has a mean molecular mass ranging between 20 claim 18 ,000 and 80 claim 18 ,000 Da.20. Balloon according to claim 16 , wherein the active substance is arranged on a surface of the balloon and the polysaccharide covers the active substance.21. Balloon catheter claim 16 , comprising a balloon according to any of the preceding to .22. Method for coating a balloon of a balloon catheter claim 16 , said balloon being coated on a surface with a lipophilic active substance claim 16 , whereinthe active-substance-coated surface of the balloon is moistened at least partly with a solution containing at least one polysaccharide having a mean molecular mass of 10,000 Da to 100,000 Da and at least one solvent, andthe solvent is separated from the polysaccharide.23. Method according to claim 22 , wherein the balloon is ...

Подробнее
26-12-2013 дата публикации

CARRIERS FOR HEMOSTATIC TRACT TREATMENT

Номер: US20130345636A1
Принадлежит: ABBOTT LABORATORIES

Apparatuses and methods for administering a hemostatic agent to the tissue surrounding an opening in a body lumen are disclosed. The apparatus can include a tissue-contacting region and an optional body lumen-penetrating region. At least one hemostatic agent is included as a component of a coating over and/or a mixture with the material of at least a portion of the tissue-contacting region. 1. An apparatus for administration of at least one hemostatic agent to a tissue surrounding an opening in a wall of a body lumen , the apparatus comprising:an elongate element that includes a tissue-contacting region, a proximal end, a distal end, and a lumen extending therebetween; andat least one hemostatic agent disposed on the tissue-contacting region.2. The apparatus as recited in claim 1 , wherein the tissue-contacting region includes at least a portion of the elongate claim 1 , substantially cylindrical element that is capable of contacting non-vascular tissues surrounding a venous or arterial puncture site without being inserted into or contacting an inside portion of the vein or artery.3. The apparatus as recited in claim 1 , the at least one hemostatic agent is included as a component of a coating over and/or a mixture with a material that defines the tissue-contacting region.4. The apparatus as recited in claim 1 , the elongate element includes a body lumen-penetrating region.5. The apparatus as recited in claim 4 , the body lumen-penetrating region being substantially devoid of hemostatic agent.6. An apparatus for administration of at least one hemostatic agent to a tissue surrounding an opening in a wall of a body lumen claim 4 , the apparatus comprising:an elongate element that includes a tissue-contacting region, a body lumen-penetrating region, a proximal end, a distal end, and a lumen extending therebetween;at least one hemostatic agent disposed on the tissue-contacting region, the body lumen-penetrating region being substantially devoid of the hemostatic agent; ...

Подробнее
02-01-2014 дата публикации

COATING OF A DRUG-ELUTING MEDICAL DEVICE

Номер: US20140004170A1
Принадлежит: CAPSULUTION PHARMA AG

The present invention relates to a method for preparing a drug-eluting implantable or insertable medical device comprising the steps of (i) providing a implantable or insertable medical device having a surface, (ii) depositing at least two oppositely charged polyelectrolyte layers on at least a portion of said surface to form a polyelectrolyte multilayer on the surface, and (iii) depositing one or more layers of particulate pharmaceutically active ingredient within said polyelectrolyte multilayer or on top of said polyelectrolyte multilayer. The invention also pertains to a drug-eluting implantable or insertable medical device obtained by such a method and the medical uses of such devices. 1. A method for preparing a drug-eluting implantable or insertable medical device comprising:(i) providing an implantable and/or insertable medical device comprising a surface,(ii) depositing at least two oppositely charged polyelectrolyte layers on at least a portion of said surface to form a polyelectrolyte multilayer on the surface, and(iii) depositing at least one layer of particulate pharmaceutically active ingredient within said polyelectrolyte multilayer and/or on top of said polyelectrolyte multilayer.2. The method according to claim 1 , wherein deposition of the polyelectrolyte layers is performed at a non-physiological pH at which the two polyelectrolytes are oppositely charged and wherein at least one polyelectrolyte is an amphoteric substance which comprises a different net charge at a physiological pH such that the two polyelectrolytes comprise the same net charge at a physiological pH.3. The method according to claim 1 , wherein at least one of the two oppositely charged polyelectrolyte layers comprises the particulate pharmaceutically active ingredient.4. The method according to claim 1 , wherein the particulate pharmaceutically active ingredient comprises a particle size of from 10 nm to 100 μm claim 1 , optionally from 0.5 μm to 3 μm.5. The method according claim ...

Подробнее
16-01-2014 дата публикации

SILICONE RUBBER-BASED CURABLE COMPOSITION, METHOD FOR PRODUCING SILICONE RUBBER, SILICONE RUBBER, MOLDED ARTICLE, AND TUBE FOR MEDICAL USE

Номер: US20140018464A1
Принадлежит: SUMITOMO BAKELITE CO., LTD.

The present invention provides a silicone rubber-based curable composition with which a silicone rubber having excellent tensile strength and tear strength is obtained, a method for producing a silicone rubber using the silicone rubber-based curable composition, a silicone rubber, a molded article using the silicone rubber, and a tube for medical use formed from the molded article. The silicone rubber-based curable composition of the present invention is characterized in that it includes a vinyl group-containing organopolysiloxane (A), an organohydrogen polysiloxane (B), silica particles (C), a silane coupling agent (D), and platinum or a platinum compound (E). 1. A silicone rubber-based curable composition comprising:a vinyl group-containing organopolysiloxane (A);an organohydrogen polysiloxane (B);silica particles (C);a silane coupling agent (D); andplatinum or a platinum compound (E).2. The silicone rubber-based curable composition according to claim 1 , which is formed by obtaining a kneaded product containing the vinyl group-containing organopolysiloxane (A) claim 1 , the silica particles (C) claim 1 , and the silane coupling agent (D) claim 1 , and then kneading the kneaded product with the organohydrogen polysiloxane (B) and the platinum or platinum compound (E).3. The silicone rubber-based curable composition according to claim 2 , wherein the kneaded product is obtained by kneading the vinyl group-containing organopolysiloxane (A) with the silane coupling agent (D) in advance claim 2 , and then kneading the silica particles (C) therewith.4. The silicone rubber-based curable composition according to claim 2 , which is obtained by kneading the organohydrogen polysiloxane (B) with the kneaded product claim 2 , kneading the platinum or platinum compound (E) with the kneaded product claim 2 , and then kneading them with each other.5. The silicone rubber-based curable composition according to claim 1 , further comprising water (F).6. The silicone rubber-based ...

Подробнее
23-01-2014 дата публикации

Cloned biological material medical device and method thereof

Номер: US20140023687A1
Автор: Keith A Raniere
Принадлежит: First Principles Inc

A medical device, said medical device, comprises: a first component having a non-biological material; a second component having a cloned biological material, said second component being attached to said first component, wherein said first component and said second component are operatively associated in a non-living medical device for at least one of treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism. In another aspect, a method comprises: preparing a cloned biological material from a tissue or an organ; attaching said biological material to a medical device; interfacing said biological material with the non-biological material; providing treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism.

Подробнее
23-01-2014 дата публикации

COATINGS WITH TUNABLE SOLUBILITY PROFILE FOR DRUG-COATED BALLOON

Номер: US20140025005A1
Принадлежит: Abbott Cardiovascular Systems Inc.

A drug delivery balloon is provided, the a balloon having an outer surface, and a tunable coating disposed on at least a length of the balloon surface. The tunable coating includes a first therapeutic agent and a first excipient, and a second therapeutic agent and a second excipient. The first and second therapeutic agents have different dissolution rates during balloon inflation and therefore provide a coating that is tunable. 1. A balloon for delivery of a drug , the balloon comprising:a body having an outer surface; anda coating disposed on at least a length of the outer surface, the tunable coating including zotarolimus and at least one excipient including polyvinylpyrrolidone or polyethylene glycol, the coating having a dissolution time of about 10 seconds to about 1 hour, wherein the at least one excipient increases the solubility of the zotarolimus to between about 4 ug/ml to about 1437 ug/ml.2. The balloon of claim 1 , wherein the at least one excipient is blended with a contrast agent.3. The balloon of claim 1 , wherein the at least one excipient includes a polymer having a molecular weight of less than about 35 kDalton.4. The balloon of claim 1 , wherein the at least one excipient includes a polymer having a molecular weight greater than about 100 kDalton.5. The balloon of claim 1 , wherein the coating further includes a plasticizer.6. The balloon of claim 5 , wherein the plasticizer is glycerol.7. The balloon of claim 1 , wherein the dissolution rate is about 10 seconds to 10 minutes.8. A balloon for delivery of a therapeutic agent claim 1 , the balloon comprising:a body having an outer surface; anda coating disposed on at least a length of the outer surface, the coating including a first therapeutic agent and a first excipient having a first dissolution rate, and a second therapeutic agent and a second excipient having a second dissolution rate, wherein the first therapeutic agent is zotarolimus, the first excipient is polyvinylpyrrolidone or ...

Подробнее
30-01-2014 дата публикации

NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE

Номер: US20140030307A1
Принадлежит: IASOMAI AB

A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent. 1. A medical product comprising ,(i) N-acetyl-L-cysteine;(ii) selenium in the form of selenomethionine; and(iii) melatoninand/or physiologically acceptable salts thereof.2. The medical product of claim 1 , wherein components (i)-(iii) are provided as separate dosage units.3. The medical product of claim 1 , further comprising an additional active compound.4. The medical product of claim 3 , wherein the additional active compound comprises a germicidal drug claim 3 , noble metal solution claim 3 , and/or dexamethasone.5. The medical product of claim 1 , wherein N-acetyl-L-cysteine is present at a concentration of 3-10 wt. % claim 1 , selenomethionine is present at a concentration of 0.3-1 wt. % claim 1 , and melatonin is present at a concentration of 0.01-0.2 wt. %.6. A hydrogel coating comprising the medical product of .7. A medical device comprising the hydrogel coating of .8. The medical device of claim 7 , wherein the hydrogel coating is incorporated into a plastic material of the medical device.9. A method of using the medical device of claim 7 , which comprises exposing the hydrogel coating to bodily fluids.10. A method of treating benign or malignant neoplasies claim 1 , which comprises administering the medical product of .11. A method of treating dermatological diseases claim 1 , which comprises administering the medical product of .12. A method of cosmetically treating skin claim 1 , which comprises administering the medical product of .13. A method of treating bacterial infections claim 1 , which comprises administering the medical ...

Подробнее
30-01-2014 дата публикации

MEDICAL APPLIANCE HAVING A SLIDABLE COATING LAYER AND SYRINGE

Номер: US20140031764A1
Принадлежит: TERUMO KABUSHIKI KAISHA

A medical appliance including a slidable coating layer moves in contact with an inner surface of a medical member or that of a lumen. The medical appliance has the slidable coating layer formed at a part thereof which contacts the medical member or the lumen. The slidable coating layer is formed of a composition containing a solventless-type hardening silicone-based resin. 1. A medical appliance , comprising a slidable coating layer which moves while in contact with an inner surface of a medical member or an inner surface of a lumen ,wherein said slidable coating layer is formed at a part of the medical appliance which contacts said medical member or said lumen,wherein said slidable coating layer is formed of a composition containing solventless hardening silicone-based resin.2. The medical appliance having a slidable coating layer according to claim 1 , wherein said composition does not contain a tin-based compound.3. The medical appliance having a slidable coating layer according to claim 1 , wherein said solventless hardening silicone-based resin has a viscosity of 30 to 500 mPa·s at 25° C. before said solventless hardening silicone-based resin hardens.4. The medical appliance having a slidable coating layer according to claim 1 , wherein the solventless hardening silicone-based resin is a product of an addition reaction between silicone having at least two vinyl groups and a branch structure and silicone having at least two hydrogen groups bonded to the same silicon atom.5. The medical appliance having a slidable coating layer according to claim 4 , wherein said silicone-based resin of said composition is formed by hydrosilylation between said vinyl groups of said silicone having said vinyl groups and said branch structure and silicon bonded to said hydrogen groups of said silicone having said hydrogen groups bonded to said silicon atom.6. The medical appliance having a slidable coating layer according to claim 4 , wherein said silicone having said branch ...

Подробнее
06-02-2014 дата публикации

Sterilizable indwelling catheters

Номер: US20140039418A1
Принадлежит: Boston Scientific Scimed Inc

According to an aspect of the invention, an indwelling catheter is provided which comprises a catheter shaft. The catheter either comprises a light source or is adapted to receive light from a light source, and is configured such that light is transmitted from the light source into the catheter shaft. Moreover, the catheter shaft is formed of a polymeric material that transmits a quantity of light from the light source that is effective to inactivate microorganisms on a surface of the catheter shaft upon activation of the light source. For example, the light may inactivate the microorganisms directly or in conjunction with a photosensitizer. According to another aspect of the invention, a sterilization method is provided, which comprises activating the light source while the catheter is inserted in a subject.

Подробнее
13-02-2014 дата публикации

DRUG COATED BALLOON CATHETER AND PHARMACOKINETIC PROFILE

Номер: US20140046254A1
Принадлежит: Abbott Cardiovascular Systems Inc.

A drug delivery balloon is provided comprising a balloon having a surface, and a coating disposed on at least a portion of the balloon surface, the coating including an cytostatic therapeutic agent, an excipient, and a plasticizer. In accordance with the present subject matter, at least 30% of the coating transfers from the balloon surface within two minutes after inflation of the balloon. Alternatively, at least 30% of the coating transfers from the balloon surface within one minute after inflation. The coating results in an effective pharmacokinetic profile of an cytostatic therapeutic agent in a vasculature or target tissue. 1. A drug delivery balloon comprising:a balloon having a surface; anda coating disposed on at least a portion of the surface, wherein the coating includes having a cytostatic therapeutic agent, an excipient, and a plasticizer, and further wherein at least 30% of the coating transfers from the balloon surface within two minutes after inflation of the balloon.2. The drug delivery balloon of claim 1 , wherein at least 50% of the coating transfers from the balloon surface within two minutes after inflation of the balloon.3. The drug delivery balloon of claim 1 , wherein at least 75% of the coating transfers from the balloon surface within two minutes after inflation of the balloon.4. The drug delivery balloon of claim 1 , wherein at least 90% of the coating transfers from the balloon surface within two minutes after inflation of the balloon.5. The drug delivery balloon of claim 1 , wherein the cytostatic drug is zotarolimus.6. The drug delivery balloon of claim 1 , wherein the cytostatic drug is everolimus claim 1 , sirolimus claim 1 , bicytostatic claim 1 , mycytostatic claim 1 , deforcytostatic claim 1 , or temsirolimus.7. The drug delivery balloon of claim 1 , wherein the excipient is polyvinylpyrrolidone.8. The drug delivery balloon of claim 1 , wherein the excipient is a polysorbate.9. The drug delivery balloon of claim 1 , wherein the ...

Подробнее
20-02-2014 дата публикации

Flocked medical tube

Номер: US20140052111A1
Принадлежит: Aesculap AG

A medical tube, especially for use in vacuum therapy, preferably endoluminal vacuum therapy, comprising at least one tube body and a flock material is described. A process for producing a medical tube comprises: coating the surface of at least one tube body with an adhesive at least partially, especially partially or completely, and flocking the adhesive-coated tube body with a flock material, while the adhesive is moist, adhesive or sticky, or after activating the adhesive. Alternatively, a process for producing a medical tube comprises: at least partial transformation of at least one tube body into an adhesive or sticky state and flocking of the at least partially adhesive or sticky tube body with a flock material. In addition, a drainage system, especially in the form of a kit is described.

Подробнее
27-02-2014 дата публикации

Drug eluting sculpting balloon

Номер: US20140058358A1
Автор: Elias H. Kassab
Принадлежит: KASSAB KUGHN ENDOVASCULAR DEVICES LLC

A plaque-modifying balloon and method for use in an endovascular procedure includes an elongated balloon that defines a longitudinal axis and is inflatable from a first deflated configuration to a second radially expanded configuration. One or more plaque-modifying elements are mounted on the outside of the inflatable balloon. Optionally, a compressible sheath made of a relatively low durometer, flexible material is mounted on the balloon to cover the elements during transit of the plaque-modifying balloon to and from the treatment site.

Подробнее
06-03-2014 дата публикации

Hppe member and method of making a hppe member

Номер: US20140065419A1
Принадлежит: DSM IP ASSETS BV

The invention concerns a high performance polyethylene (HPPE) member comprising at least 5 wt-% of a radiopaque component, the HPPE member is biocompatible and the radiopaque component is a particulate at least partially arranged inside a HPPE filament of the HPPE member. Furthermore, the radiopaque component has a particle size of at most 1 μm, preferably the radiopaque component has a particle size if at most 0.5 μm. The invention also concerns a method of making the HPPE member and various medical devices and repair products comprising the HPPE member.

Подробнее
06-03-2014 дата публикации

Retractable sheath devices, systems, and methods

Номер: US20140066897A1
Принадлежит: WL Gore and Associates Inc

The invention is directed to delivery medical devices that enable consistent “on-demand” delivery of therapeutic agents to a vessel. The medical device of the current invention comprises retractable sheath comprising neckable elements. The medical device of the current invention comprises an expandable member, a hydrophilic coating comprising at least one therapeutic agent about the expandable member or structural layer and a retractable outer sheath with a selectively permeable microstructure. The design and methods disclosed herein ensures that therapeutic agent delivery occurs essentially only during retraction of the outer sheath, minimizing coating and/or therapeutic agent loss to the bloodstream and providing controlled delivery to the treatment site.

Подробнее
13-03-2014 дата публикации

DIRECT FLUID COATING OF DRUG ELUTING BALLOON

Номер: US20140072695A1
Принадлежит: Abbott Cardiovascular Systems Inc.

A system and method for coating an expandable member of a medical device comprises providing a dispenser in fluid communication with a fluid source with the dispenser having at least one outlet to dispense fluid of the fluid source therefrom. The outlet(s) of the dispenser is positioned proximate a surface of an expandable member, with relative movement between the outlet(s) and the surface of the expandable member established along a coating path, and fluid is dispensed from the dispenser to form a substantially continuous bead of fluid between the at least one outlet and the surface of the expandable member along the coating path, and simultaneously drying the fluid while dispensing the fluid from the dispenser to control flow of fluid on the surface of the expandable member. The fluid source can include a variety of therapeutic agents. 1. A method of coating an expandable member of a medical device , comprising:providing a dispenser in fluid communication with a fluid source, the dispenser having at least one outlet to dispense fluid of the fluid source therefrom;positioning the at least one outlet of the dispenser proximate a surface of an expandable member;establishing relative movement between the at least one outlet and the surface of the expandable member along a coating path;dispensing fluid from the dispenser to form a substantially continuous bead of fluid between the at least one outlet and the surface of the expandable member along the coating path; andsimultaneously drying the fluid while dispensing the fluid from the dispenser to control flow of fluid on the surface of the expandable member.2. The method of claim 1 , wherein the fluid remains substantially in a location where it contacts the surface of the expandable member.3. The method of claim 1 , wherein relative movement provides a velocity ranges approximately from 2 to 20 cm/sec.4. The method of claim 1 , wherein the dispenser is selected from the group consisting of pipet claim 1 , tubing ...

Подробнее
27-03-2014 дата публикации

Intra-luminal access apparatus and methods of using the same

Номер: US20140088560A1
Принадлежит: CORNELL UNIVERSITY

Apparatus and methods providing intra-luminal access and, in particular, to needle, catheter, and guidewire structures and methods of using the same to access a vascular or other body tissue lumen.

Подробнее
04-01-2018 дата публикации

Multi-sensor platform for diagnosing catheter status

Номер: US20180000421A1
Автор: Brian J. Kim
Принадлежит: University of Southern California USC

A multi-sensor system may include a catheter that has lumen, is flexible, is made of a polymer, and has a circular cross section that has an outer diameter of no more than 0.5 cm; and one or more sensors that sense multiple characteristics of material flowing within the lumen, including at least two of the following: flow rate, pressure, and composition of the material. A multi-sensor system may include a catheter that has lumen, is flexible, is made of a polymer, and has a circular cross section that has an outer diameter of no more than 0.5 cm; and one or more sensors that sense multiple characteristics of material flowing within the lumen, including at least two of the following: flow rate, pressure, and composition of the material.

Подробнее
06-01-2022 дата публикации

PERFUSION BALLOON WITH AN EXPANDABLE INTERNAL LUMEN

Номер: US20220001150A1
Автор: Akpinar Mehmet Hakan
Принадлежит:

The present invention relates to a perfusion balloon catheter that has an expandable (enlargeable) inner lumen with a novel design feature that allows a continuous flow through this enlarged lumen sufficient perfusion to the distal lumen of the blood vessel or air passage concurrent to and independently of balloon inflation or deflation resulting in the prolonged dilatation and avoiding the high risks of blood or air flow stricture during balloon inflation. 1. A perfusion balloon catheter device which creates pulsative perfusion of air , blood or any liquid during balloon inflation in trachea , blood vessel , artery or vein with a constant flow , characterized by comprising;{'b': 114', '101, 'An internal lumen () made of Nylon-12, polyether block amide (PEBA), or polyurethane (PU) attached to the external surface of the self/mechanically expandable stent frame (),'}{'b': '101', 'a self/mechanically expandable stent frame () utilized as a skeleton to increase the cross-section of the blood perfusion lumen to create sufficient blood perfusion to the distal vessel or tissues which is made of a shape-memory metallic wire,'}{'b': '102', 'an inner lumen () for the balloon catheter system used as a guidewire lumen made of Nylon-12, polyether block amide (PEBA), or polyurethane (PU),'}{'b': '103', 'a radiopaque marker band () made of platinum-iridium to visualize the balloon location under fluoroscopy,'}{'b': '105', 'a kink-resistant inflation lumen () for the balloon catheter made of Nylon-12, polyether block amide (PEBA), or polyurethane (PU),'}{'b': 106', '101', '102, 'a connecting strut () of the self/mechanically expandable stent frame () to the external surface of the inner lumen () made of shape-memory metallic wire,'}{'b': '107', 'a balloon catheter main shaft () to push and pull the total system made of Nylon-12, polyether block amide (PEBA), or polyurethane (PU),'}{'b': '108', 'one or more fenestration holes () to create perfusion of the connection part of the ...

Подробнее
02-01-2020 дата публикации

CERAMIC PARTICLE CARRYING MEDICAL TUBE AND/OR CUFF

Номер: US20200000684A1
Принадлежит:

It is an object of the present invention to provide a ceramic particle carrying medical tube and/or cuff excellent in cell adhesive property and the like. 1. A medical tube and/or cuff carrying a ceramic particle in at least a part thereof , whereinthe ceramic particle has a particle diameter within a range of 10 nm to 700 nm,the ceramic particle is a calcium phosphate sintered body particle, andthe ceramic particle contains no calcium carbonate.2. The medical tube and/or cuff according to claim 1 , wherein the ceramic particle is spherical.3. A medical tube and/or cuff carrying a ceramic particle in at least a part thereof claim 1 , whereinthe ceramic particle has a minor axis maximum diameter of 30 nm to 5 μm and a major axis of 75 nm to 10 μm, grows in a c axis direction, and has an aspect ratio of a crystal (c axis length/a axis length) of 1 to 30,the ceramic particle is a calcium phosphate sintered body particle, andthe ceramic particle contains no calcium carbonate.4. The medical tube and/or cuff according to claim 1 , wherein the ceramic particle is a hydroxyapatite sintered body particle.5. The medical tube and/or cuff according to claim 1 , wherein the ceramic particle contains no alkali metal elements.6. The medical tube and/or cuff according to claim 1 , wherein the ceramic particle contains carbonate apatite at least on a surface thereof.7. The medical tube and/or cuff according to claim 1 , wherein the ceramic particle satisfies the following property (A): (A) the medical tube and/or cuff shows a reduction in weight of 2% or less in a temperature range of 25° C. to 200° C. when sufficiently dried claim 1 , left to stand for 3 days or more under conditions of normal pressure claim 1 , a temperature of 25° C. claim 1 , and a humidity of 50% claim 1 , and then measured for the weight under conditions of a nitrogen stream and 10° C./min by using a thermogravimetric differential thermal analyzer (TG-DTA claim 1 , EXSTAR6000 manufactured by Seiko Instruments ...

Подробнее
07-01-2016 дата публикации

LOCAL DELIVERY OF WATER-SOLUBLE OR WATER-INSOLUBLE THERAPEUTIC AGENTS TO THE SURFACE OF BODY LUMENS

Номер: US20160000975A1
Принадлежит:

A method and device for local delivery of a water-insoluble therapeutic agent to the tissue of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with a non-durable coating which comprises poly(HEMA) complexed with iodine and has a substantially water-insoluble therapeutic agent dispersed therein. The medical disposable device is inserted into a body lumen, and expanded to contact the non-durable coating against the body lumen and deliver the substantially water-insoluble therapeutic agent to the body lumen tissue. 122-. (canceled)23. A method comprising:coating a medical disposable device having an expandable structure with a polymer coating including a poly(hydroxyethyl methacrylic) acid complexed with iodine and a substantially water-insoluble therapeutic agent;introducing the medical disposable device into a body lumen;expanding the expandable structure of the medical disposable device to contact the polymer coating against the body lumen, thereby delivering the substantially water-insoluble therapeutic agent to the body lumen; andcontracting the expandable structure.24. The method of claim 23 , further comprising withdrawing a protective sheath from over the expandable structure prior to expanding the expandable structure.25. The method of claim 23 , further comprising contacting the polymer coating against an atheroscolerotic lesion or a restenotic lesion.26. The method of claim 23 , wherein the substantially water-insoluble therapeutic agent is selected from the group consisting of anti-proliferative agents claim 23 , anti-platelet agents claim 23 , anti-inflammatory agents claim 23 , anti-thrombotic agents claim 23 , and thrombolytic agents.27. The method of claim 23 , wherein the substantially water-insoluble therapeutic agent is paclitaxel.28. The method of claim 23 , wherein at least 50% of the polymer coating is dissolved within 180 seconds of expanding ...

Подробнее
07-01-2016 дата публикации

Drug Composition and Coating

Номер: US20160000977A1
Принадлежит:

According to the invention there is provided inter alia a medical device for delivering a therapeutic agent to a tissue, the device having a solid surfactant-free particulate coating layer applied to a surface of the device, the coating layer comprising a therapeutic agent and at least one non-polymeric organic additive which is hydrolytically stable; wherein at least a proportion of the particulate coating layer comprising the therapeutic agent and the at least one organic additive melts as a single phase at a lower temperature than the melting point of the therapeutic agent and the at least one organic additive when in pure form; wherein the therapeutic agent is paclitaxel; and wherein the therapeutic agent, when formulated in the coating layer, is stable to sterilization. 1. A medical device for delivering a therapeutic agent to a tissue , the device having a solid surfactant-free particulate coating layer applied to a surface of the device , the coating layer comprising a therapeutic agent and at least one non-polymeric organic additive which is hydrolytically stable; wherein at least a proportion of the particulate coating layer comprising the therapeutic agent and the at least one organic additive melts as a single phase at a lower temperature than the melting point of the therapeutic agent and the at least one organic additive when in pure form; wherein the therapeutic agent is paclitaxel; and wherein the therapeutic agent , when formulated in the coating layer , is stable to sterilization.2. A method for preparing a medical device according to claim 1 , which comprises the steps of combining the therapeutic agent and the at least one organic additive in powder form claim 1 , and then applying the powder to the device to form a solid particulate composition and optionally applying a subsequent thermal treatment step. The present invention relates to solid paclitaxel compositions, medical devices with coatings comprising solid paclitaxel compositions and to ...

Подробнее
07-01-2021 дата публикации

Oleophilic Lubricated Catheters

Номер: US20210001011A1
Принадлежит: Hollister Inc

A medical device wherein the device has an outer surface coated with an oleophilic lubricous coating or the device is formed from a mixture including a polymer and an oleophilic compound.

Подробнее
07-01-2021 дата публикации

MEDICAL DEVICE AND METHOD FOR PRODUCING MEDICAL DEVICE

Номер: US20210001012A1
Автор: TAKEMURA Naoto
Принадлежит: TERUMO KABUSHIKI KAISHA

A medical device includes: a base material; and a coating on a surface of the base material, the coating comprising silicone and a compound comprising a constituent unit represented by the following Formula (I): 2. The medical device according to claim 1 , wherein the coating comprises a cross-linked silicone.3. The medical device according to claim 1 , wherein the compound is polymethoxyethyl acrylate.4. The medical device according to claim 2 , wherein the compound is polymethoxyethyl acrylate.5. The medical device according to claim 2 , wherein the coating further comprises a silicone oil.6. The medical device according to claim 5 , wherein the coating has a structure in which a lower layer comprises the compound and the cross-linked silicone claim 5 , and an upper layer comprises the silicone oil.8. The method according to claim 7 , wherein: immersing the surface of the base material in a mixed solution comprising a cross-linked silicone and the compound, and', 'pulling the surface of the base material out of the mixed solution, and', 'drying the base material that has been pulled out of the mixed solution to form the coating on the surface of the base material., 'the step of forming the coating comprises9. The method according to claim 8 , wherein: immersing the surface of the base material, with the coating thereon, in a solution comprising a silicone oil, and', 'pulling the surface of the base material out of the solution, and', 'drying the base material that has been pulled out of the solution so as to form a layered coating that has a structure in which a lower layer comprises the compound and the cross-linked silicone, and an upper layer comprises the silicone oil., 'the step of forming the coating further comprises9. The method according to claim 7 , wherein the compound is polymethoxyethyl acrylate.10. The method according to claim 8 , wherein the compound is polymethoxyethyl acrylate.12. The catheter according to claim 11 , wherein the coating comprises ...

Подробнее
04-01-2018 дата публикации

Systems, devices, and methods for embedding drug molecules into medical catheters or tubes

Номер: US20180000993A1
Автор: Jie Zhang
Принадлежит: SPARKMED RESEARCH LLC

The present disclosure relates to methods for embedding drug molecules into medical catheters, tubes, and other medical devices. The catheter, tube, or other medical device is capable of releasing drugs for extended periods of time. Drugs can be loaded into the wall thereof through diffusion from a solution, e.g., loading solution. A counterintuitive approach of using undissolved drug particulates in the solution is employed in some embodiments. The drug in the wall of the device and in the solution (which when stored may be referred to as a storage solution) can be in dynamic equilibrium, yielding stable and easy-to-manufacture products. Heat can be used to significantly speed up the drug loading.

Подробнее
04-01-2018 дата публикации

DEVICE FOR FLUID TRANSFER MADE IN NANOMATERIAL

Номер: US20180000995A1
Принадлежит:

A continuously hollow device for the transfer of fluids to the human body is provided, which is made in a nanomaterial derived from latex, which chemical composition in based primarily on fats, waxes and several gummy resins obtained from cytoplasm of lactic cells. This biochemically modified material is capable of adjusting its outer and inner diameter, i.e. it enlarges or shrinks according to the needs of the patient. The device corresponds to a needle or the like (catheter), which allows to have a very small diameter so as to be inserted in the patient (minimally invasive procedure) and after a physical excitation of such nanomaterial, it can be extended once inserted in the body so as to allow the intake or discharge of fluids to or from the body through a catheter, probe or the like. 1. A minimally invasive , biomedical device consisting of needle or catheter manufactured in a latex-derived nanomaterial which chemical composition is fundamentally based in fats , waxes and diverse gummy resins obtained from cytoplasm of lactic cells.2. The device according to claim 1 , further comprising:a nanosensor located along the needle or catheter and generating an LEP-type optic stimulus along its path in order to activate the laboratory modified latex and which modifies its molecular structure;a container for storing the liquid to be injected to removed;a control system directly connected to the sensor; anda power source which provides the necessary power to all the elements.3. The device according to claim 1 , wherein the nanosensor activates with a device which connected to the power source can provide the optic claim 1 , electric or magnetic stimulus which generates the molecular modification of latex used in the manufacture of the needle or catheter.4. The device according to claim 1 , having a shutter which allows the activation and deactivation of the nanosensor at will of the health personnel. This application claims priority to PCT Application No. PCT/IB2015/ ...

Подробнее
07-01-2016 дата публикации

MEDICAL DEVICE WITH A STRUCTURED COATING

Номер: US20160001062A1
Принадлежит:

A medical device includes a tubular body having a distal end and a proximal end, a lumen extending through the tubular body from the distal end to the proximal end, a wire extending through the lumen from the distal end to the proximal end, and a polymeric coating. The wire has an outer surface. The polymeric coating is on at least a portion of the outer surface of the wire. The coating comprises a bulk material and a plurality of flexible microstructures disposed on the bulk material. The microstructures extend outwardly from a surface of the polymeric coating. 1. A medical device comprising:a catheter having a distal end and a proximal end;a lumen extending through the catheter from the distal end to the proximal end;a drive shaft extending through the lumen from the distal end to the proximal end, wherein the drive shaft is a helically coiled wire having an outer surface; anda polymeric coating on at least a portion of the outer surface of the drive shaft, wherein the coating comprises a bulk material and a plurality of flexible microstructures disposed on the bulk material, wherein the microstructures extend outwardly from a surface of the polymeric coating.2. The medical device of claim 1 , wherein the flexible microstructures include a first end and a second end claim 1 , and the distance from the first end to the second end is from 5 micrometers to 100 micrometers.3. The medical device of claim 1 , wherein the microstructures are integral with the polymeric coating.4. The medical device of claim 1 , wherein the coating includes at least one member selected from the group consisting of ethylene tetrafluoroethylene (ETFE) and polyethylene terephthalate (PET).5. The medical device of claim 1 , and further comprising a protective coating on at least a portion of the flexible microstructures.6. The medical device of claim 5 , wherein the protective coating has a thickness of 3 nanometers to 30 nanometers.7. The medical device of claim 5 , wherein the protective ...

Подробнее
04-01-2018 дата публикации

URINARY CATHETER WITH VARYING PROPERTIES

Номер: US20180001055A1
Принадлежит:

A urinary catheter and a method of its manufacture are disclosed. The urinary catheter comprises a tubular shaft extending between an insertion end and a discharge end, the tubular shaft being formed of at least two materials having different properties. The materials are arranged substantially separated from each other in distinct zones, wherein at least one of the width and thickness of said zones varies over the length of the tubular shaft, to form two or more uniform sections of the tubular shaft having various relative amounts of said materials, and wherein at least one transition between two such uniform sections is formed by at least one transition section providing a gradual transition between the uniform sections. The catheter can e.g. be produced by intermittent extrusion. 1. A urinary catheter comprising a tubular shaft extending between an insertion end and a discharge end , the tubular shaft being formed of at least two materials having different properties , each of said materials being arranged substantially separated from each other in distinct zones , wherein at least one of a width or thickness of said zones varies over the length of the tubular shaft , to form two or more uniform sections of the tubular shaft having various relative amounts of said materials , and wherein at least one transition between two such uniform sections is formed by at least one transition section providing a gradual transition between said uniform sections.2. The urinary catheter of claim 1 , wherein each transition section has an extension within the range of 2-30% of the total length of the tubular shaft.3. The urinary catheter of claim 1 , wherein each transition section has an extension within the range of 4-20% of the total length of the tubular shaft.4. The urinary catheter of claim 1 , wherein each transition section has an extension within the range of 5-10% of the total length of the tubular shaft.5. The urinary catheter of claim 1 , wherein the two or more ...

Подробнее
04-01-2018 дата публикации

INTRODUCER SHEATH AND INTRODUCER

Номер: US20180001061A1
Принадлежит: TERUMO KABUSHIKI KAISHA

An introducer sheath is disclosed, which includes a tube body that is percutaneously inserted into a body lumen; and a hub that is connected to a proximal portion of the tube body. The tube body contains a polyvinylidene fluoride resin, a ratio of a thickness to an inner diameter of the tube body is 1/16 or lower, and a ration of a kink radius to an outer diameter of the tube body is 9.5 or lower. 1. An introducer sheath comprising:a tube body that is percutaneously inserted into a body lumen; anda hub that is connected to a proximal portion of the tube body,wherein the tube body contains a polyvinylidene fluoride resin, andwherein a ratio of a thickness to an inner diameter of the tube body is 1/16 or lower, and a ratio of a kink radius to an outer diameter of the tube body is 9.5 or lower.2. The introducer sheath according to claim 1 ,wherein the tube body is provided with a tapered tube distal portion and a tube main body portion positioned on the proximal side of the tube distal portion, andwherein a ratio of a thickness to an inner diameter of the tube main body portion is 1/16 or lower, and a ratio of a kink radius to an outer diameter of the tube main body portion is 9.5 or lower.3. The introducer sheath according to claim 2 ,wherein the tube body is configured to be provided with the tube distal portion that is harder than the tube main body portion.4. The introducer sheath according to claim 1 , further comprising:a strain relief portion that covers an interlock portion between the tube body and the hub, andwherein the tube body is configured to have a proximal end of the tube body that is fixed to a lumen of the hub, and a kink generation angle is 38° or larger when the tube body is pressed at a position that is 3 cm away from the distal end of the hub in a state in which the stress relief portion is provided.5. The introducer sheath according to claim 2 , further comprising:a strain relief portion that covers an interlock portion between the tube body and ...

Подробнее
03-01-2019 дата публикации

POLYTETRAFLUOROETHYLENE CO-POLYMER EMULSIONS

Номер: US20190000979A1
Принадлежит:

The present disclosure is directed to a class of fluorinated copolymers, such as PTFE copolymers, that can be dissolved in low toxicity solvents, such as Class III Solvents, and that enable the creation of stable water-in-solvent emulsions comprising the fluorinated copolymers dissolved in a low toxicity solvents and a hydrophilic agent (e.g., a therapeutic agent) dissolved in an aqueous solvent, such as water or saline. 1. A method of preparing a water in solvent emulsion comprising the steps of:a. Dissolving a tetrafluoroethylene copolymer in a water miscible organic solvent;b. Providing a water phase;c. Dissolving an agent comprising one of a water soluble agent and a hydrophobic agent; andd. Combining the tetrafluoroethylene copolymer with the dissolved agent, such that the emulsion is kinetically stable.2. The method of claim 1 , wherein the agent is a therapeutic agent.3. The method of claim 1 , wherein the agent is an inclusion complex comprising a hydrophobic agent and a hydrophilic complexing agent.4. The method of claim 1 , wherein the agent is a water soluble agent which is dissolved into the water phase.5. A method of coating a substrate comprising a water-in-solvent emulsion claim 1 , the method comprising the steps of:a. Providing a water in solvent emulsion comprising a tetrafluoroethylene copolymer, a solvent phase comprising a water miscible organic solvent, an agent comprising one of a water soluble agent and a hydrophobic agent, a water phase, wherein the emulsion is kinetically stable;b. Applying the water-in-solvent emulsion to the substrate; andc. Removing the solvent and water.6. The method of claim 5 , wherein the agent is an inclusion complex comprising a hydrophobic agent and a hydrophilic complexing agent.7. The method of claim 5 , wherein the water phase is less than about 500 nm by Raman spectroscopy.8. The method of claim 5 , wherein the tetrafluoroethylene copolymer comprises functional groups selected from a group consisting of ...

Подробнее
03-01-2019 дата публикации

FLUID CIRCUIT HAVING REDUCED PLASTICIZER MIGRATION

Номер: US20190001026A1
Автор: Sandford Craig
Принадлежит:

A fluid flow circuit assembly for a biological fluid processing device, comprising a PVC tubing comprising a polymeric plasticizer and/or a high molecular weight plasticizer having a molecular weight of 540 g/mol or more. The fluid flow circuit assembly also comprises a medical device component comprising a bond surface to which the PVC tubing is bonded by a solvent, wherein the bond surface comprises a polyester elastomer, plasticized PVC, and/or a polycarbonate. 1. A fluid flow circuit assembly for a biological fluid processing device , comprising:a PVC tubing comprising a polymeric plasticizer and/or a high molecular weight plasticizer having a molecular weight of 540 g/mol or more; anda medical device component comprising a bond surface to which the PVC tubing is bonded by a solvent, wherein the bond surface comprises a polyester elastomer, plasticized PVC, and/or a polycarbonate.2. The fluid flow circuit assembly of claim 1 , wherein the biological fluid processing device comprises a centrifugal blood separator claim 1 , and the medical device component comprises an umbilicus comprising a thermoplastic polyester elastomeric material.3. The fluid flow circuit assembly of claim 1 , wherein the solvent comprises cyclohexanone and/or methylethylketone.4. The fluid flow circuit assembly of claim 3 , wherein the bond surface comprises at least one of a thermoplastic polyester elastomer claim 3 , a polycarbonate claim 3 , and/or plasticized PVC.5. The fluid flow circuit assembly of claim 1 , wherein the polymeric plasticizer comprises an acrylate copolymer.6. The fluid flow circuit assembly of claim 1 , wherein the medical device component comprises a port claim 1 , y-connector claim 1 , or adapter.7. The fluid flow circuit assembly of claim 1 , wherein the medical device component comprises an umbilicus having a plural number of lumen at one end of the umbilicus that is equal to a number of the PVC tubing in communication between the one end to a remainder of the ...

Подробнее
03-01-2019 дата публикации

Drug Device Electroporation System

Номер: US20190001105A9
Автор: Hatran Douglas Phat
Принадлежит: Hydra Vascular LLC

Active Energy Facilitated Drug Delivery platform for delivering therapeutics to biological tissue through electrical conductivity. This delivery method is comprised of an elastic alloy to encase a balloon or drug deposition, where the alloy acts to emit an electric field in aiding and actively allowing the pharmaceutical agent to have enhanced permeation, binding and internalization to cells and the biological matrix. A therapeutic agent is deposited onto a balloon to embody the drug deposition, reservoir whereby the electrical field facilitates the active transfer of a pharmaceutical agent to the target tissue is described. 1. A balloon catheter In which the balloon is messed within an elastic conducting alloy cage , wherein the cage is bonded at both distal and proximal balloon ends with an electrical connection at the proximal taper to conductive elements along the body of the catheter to a proximal connection to an electrical power source , and wherein the working length of the balloon and optionally the cage section are coated with materials comprising a therapeutic bio-active agent and optional excipients.2. The device of in which the elastic conducting alloy is nitinol.3. The device of whereby the electrical conducting field can be provided by en energy generator where one polarity is delivered to the emitter while the opposing polarity is grounded to the surface or body of the Intended target.4. The device of whereby the energy field is primarily voltage driven with low current.5. The device of whereby the power supply delivers a square wave with a voltage range of 0.001 kV to 5 kV.6. The device of claim in which the bio-active agents will comprise the broad classes of anti-neoplastic agents claim 1 , mTOR inhibitors claim 1 , taxanes claim 1 , neurotoxins claim 1 , steroids claim 1 , and non-steroidal anti-inflammatory agents.7. The device of claim 4 , wherein the coating is also comprised of one or more of an organic excipient such as a polymer or oligomer ...

Подробнее
02-01-2020 дата публикации

COATING COMPOSITION COMPRISED OF A HYDROPHILIC CROSSLINKER, A HYDROPHOBIC CROSSLINKER AND OPTIONALLY A HYDROGEL AND METHODS OF MAKING AND USING THE SAME

Номер: US20200002565A1
Принадлежит:

The present invention relates to coatings for devices such as medical devices that are useful for coating a variety of different types of material surfaces, including polymer and metal surfaces. The present invention also includes the method of using the coated device and methods to make the coated device and coating. 1. A coated substrate , comprising:a substrate, wherein the substrate comprises a polar characteristic at an exterior surface;and at least one crosslinkable component; and', 'at least one high molecular weight component entrapped in the at least one crosslinkable component,', 'wherein the at least one crosslinkable component induces a variable or a gradient concentration between the gradient coating adjacent to an exterior surface of the substrate and an outer surface of the gradient coating, and wherein the gradient coating adjacent to the exterior surface of the substrate comprises a first coating polar characteristic and the outer surface of the gradient coating comprises a second coating polar characteristic., 'a gradient coating comprising24-. (canceled)5. The coated substrate of claim 1 , wherein the at least one crosslinkable component comprises at least two materials claim 1 , wherein a characteristic of a material of the at least two materials is different from a characteristic of a second material of the at least two materials claim 1 , and wherein the characteristic is a polar characteristic or a density characteristic.6. (canceled)7. The coated substrate of claim 5 , wherein the polar characteristic of the exterior surface of the substrate is altered from a first polar characteristic to a second polar characteristic.8. The coated substrate of claim 7 , wherein the first polar characteristic is hydrophilic and wherein the second polar characteristic is less hydrophobic as compared to the first polar characteristic.9. The coated substrate of claim 5 , further comprising a second crosslinkable component of the at least one crosslinkable ...

Подробнее
01-01-2015 дата публикации

LINEAR POLYESTERAMIDES FROM AMINOPHENOLIC ESTERS

Номер: US20150004212A1
Принадлежит:

The present invention is directed to linear, biodegradable polyesteramide (PEA) polymers synthesized with repeating units derived from aminophenol esters and diacids. These PEAs have a monomer repeat represented by 16-. (canceled)8. A synthetic polymer as recited in claim 7 , wherein the number of repeat units is an average weight of the synthetic polymer divided by a molecular weight of bc.9. A pharmaceutical composition comprising the synthetic polymer of and one or more drugs.10. A pharmaceutical composition as recited in claim 9 , wherein the one or more drugs are selected from a group consisting of antimicrobial agents claim 9 , antibacterial agents claim 9 , aneshetics claim 9 , anti-inflammatory agents claim 9 , anti-scarring agents claim 9 , anti-fibrotic agents claim 9 , leukotriene inhibitors and chemotherapeutic agents.11. A pharmaceutical composition as recited in claim 9 , wherein the one or more drugs is an antimicrobial agent selected from a group consisting of rifampin claim 9 , minocycline claim 9 , gentamicin claim 9 , vancomycin claim 9 , triclosan claim 9 , and combinations thereof.12. A synthetic polymer as recited in claim 9 , wherein the one or more drugs are selected from a group consisting of rifampin claim 9 , minocycline claim 9 , anesthetics and anti-inflammatory agents.13. A synthetic polymer as recited in claim 7 , wherein Ris independently selected from a group consisting of hydrogen claim 7 , methyl claim 7 , ethyl claim 7 , propyl claim 7 , butyl and benzyl.14. A synthetic polymer as recited in claim 13 , wherein R is methylene or ethylene.15. A synthetic polymer as recited in claim 7 , wherein R is methylene or ethylene.16. A synthetic polymer as recited in claim 7 , wherein Ris independently selected from a group consisting of methyl claim 7 , ethyl claim 7 , n-propyl claim 7 , —CHOCH— claim 7 , —(CH)CO—(CHCHO)s—C(O)—(CH)— claim 7 , and—(CH)—O—(CHCHO)(CH)—.17. A medical device comprising the synthetic polymer of .18. A medical ...

Подробнее
20-01-2022 дата публикации

Tube-containing medical devices with bioactive luminal wire

Номер: US20220016392A1
Автор: Giridhar Thiagarajan
Принадлежит: Cathpro Technologies LLC

A tube-containing medical device assembly or tube-containing medical device kit can include a tube-containing medical device including an access opening positionable exterior with respect to a subject, a fluid communication opening positionable within the subject to fluidically communicate with a body fluid of the subject, and an elongated lumen therebetween. A luminal wire is inserted or insertable in the elongated lumen, wherein the luminal wire has a length that is within or will be positioned with 5% to 100% of the elongated lumen. The luminal wire can have an x-y cross-sectional diameter sufficiently smaller than an x-y cross-sectional diameter of the elongated lumen to allow removal and/or insertion of the luminal wire (initially or as a replacement). The luminal wire in the present disclosure is bioactive.

Подробнее
20-01-2022 дата публикации

DRUG ELUTING BALLOON AND BALLOON CATHETER

Номер: US20220016398A1
Автор: Chen Lu, Li Junfei, Li Meng
Принадлежит:

Disclosed is a drug eluting balloon for a balloon catheter. The drug eluting balloon comprises a balloon body () and a coating (), and the coating () comprises a water-soluble adhesive layer (), an isolating layer () and a drug layer () from the inside out. After the drug eluting balloon is pushed to a diseased part, the balloon body () is expanded, and the water-soluble adhesive layer () dissolves due to scouring by a blood flow, such that the isolating layer () and the drug layer () are separated from an outer surface of the balloon body () and adhere to a blood vessel wall. The provision of the isolating layer () can effectively suppress the water-soluble adhesive layer () from removing part of the drug layer () during dissolution, and after the drug layer () adheres to and makes contact with the blood vessel wall, the isolating layer can also reduce the scouring effect on the drug layer () by the blood flow, thereby reducing the loss of drugs, allowing the drugs to be taken in by the blood vessel wall to the greatest extent, greatly improving the utilization rate of the drugs and improving the treatment effect while also preventing toxic and side effects brought about by large doses of the drugs. Moreover, the isolating layer () can also realize the slow release of the drug layer (), such that the drug layer () can provide treatment for a long time, and a good treatment effect can be obtained. 1. A drug eluting balloon , comprising a balloon body and a coating layer arranged on an outer surface of the balloon body , wherein the coating layer comprises a water-soluble adhesive layer , an isolating layer and a drug layer that arranged sequentially from inside outward , wherein the water-soluble adhesive layer covers all or partial of the outer surface of the balloon body , and the isolating layer completely or incompletely covers the water-soluble adhesive layer.2. The drug eluting balloon according to claim 1 , wherein the isolating layer comprises a water- ...

Подробнее
20-01-2022 дата публикации

BALLOON DILATION CATHETER, BALLOON AND PREPARATION METHOD THEREFOR

Номер: US20220016400A1
Принадлежит:

A balloon dilation catheter, a balloon () and preparation method therefor. The balloon () is prepared by co-mixing at least two of L25, TR55, TR90, and TR70, and has high puncture resistance and low compliance with respect to a balloon () made of a single nylon material. The balloon () is preferably a hollow multilayer structure, and the puncture resistance of the balloon () can be further improved and the compliance can be further reduced with respect to a single-layer structure. 1. A balloon , wherein the balloon is made of a blend of at least two selected from the group consisting of L25 , TR55 , TR90 and TR70.2. The balloon according to claim 1 , wherein the balloon is made of a blend of L25 and TR55 claim 1 , or a blend of L25 and TR90 claim 1 , or a blend of L25 claim 1 , TR55 and TR90 claim 1 , or a blend of L25 and TR70.3. The balloon according to claim 1 , wherein the balloon is made of a blend of L25 and TR55 with a weight ratio of L25 to TR55 ranging from 9:1 to 7:3; orthe balloon is made of a blend of L25 and TR90 with a weight ratio of L25 to TR90 ranging from 9:1 to 6:4; orthe balloon is made of a blend of L25, TR55 and TR90, wherein the TR90 is present at a weight percentage of 10% and a weight ratio of L25 to TR55 ranges from 7:2 to 5:4; orthe balloon is made of a blend of L25 and TR70 with a weight ratio of L25 to TR70 ranging from 9:1 to 7:3.4. The balloon according to claim 1 , wherein the balloon is made of a blend of L25 and TR55 with a weight ratio of L25 to TR55 of 8:2; orthe balloon is made of a blend of L25 and TR90 with a weight ratio of L25 to TR90 of 7:3 or 8:2; orthe balloon is made of a blend of L25, TR55 and TR90 with an L25:TR55:TR90 weight ratio of 6:3:1; orthe balloon is made of a blend of L25 and TR70 with a weight ratio of L25 to TR70 of 9:1.5. The balloon according to claim 1 , wherein the balloon has a hollow multi-layer structure consisting of radially stacked layers of the same thickness and material.6. The balloon according ...

Подробнее
14-01-2016 дата публикации

Soft Tissue Pouch and Methods of Use Thereof

Номер: US20160008514A1
Автор: JONES Alyce Linthurst
Принадлежит: LifeNet Health

The invention relates to a soft tissue pouch and methods of use thereof. 1. A medical product comprising a medical device and a soft tissue pouch encapsulating the medical device.2. The medical product according to claim 1 , wherein the soft tissue is selected from skin claim 1 , dermis claim 1 , pericardium claim 1 , fascia claim 1 , arteries or veins claim 1 , dura mata claim 1 , ammonic membrane claim 1 , bladder claim 1 , small or large intestine.32. The medical product according to any of - claims 1 , wherein the soft tissue is an autograft claims 1 , an allograft claims 1 , or a xenograft.43. The medical product according to any of - claims 1 , wherein the soft tissue is dermis.54. The medical product according to any of - claims 1 , wherein the basement membrane side of the soft tissue is placed outward.65. The medical product according to any of - claims 1 , wherein the medical device is a pacemaker claims 1 , an ICD claims 1 , an insulin pump claims 1 , or an indwelling catheter.7. A method for preparing a soft tissue pouch for implanting a medical device into a patient claims 1 , comprising:(i) obtaining a mammalian soft tissue;(ii) optionally decellularizing and/or devitalizing the soft tissue;(iii) optionally treating the soft tissue with a plasticizer;(iv) suturing, stapling or gluing the soft tissue into a pouch shape configured to encapsulate a medical device;(v) packaging the soft tissue pouch in a packaging material; and(vi) optionally sterilizing the product.8. A method for implanting a medical device into a patient claims 1 , comprising(i) encapsulating the medical device into a soft tissue pouch;(ii) closing the opening of soft tissue pouch; and(iii) implanting the medical device with the soft tissue pouch.9. The method according to or claims 1 , wherein the soft tissue is selected from skin claims 1 , dermis claims 1 , pericardium claims 1 , fascia claims 1 , arteries or veins claims 1 , dura mata claims 1 , ammonic membrane claims 1 , bladder ...

Подробнее
14-01-2016 дата публикации

ANTIMICROBIAL COATING FORMING KINK RESISTANT FEATURE ON A VASCULAR ACCESS DEVICE

Номер: US20160008517A1
Принадлежит:

A vascular access device includes an antimicrobial coating that provides kink resistance to a catheter. The antimicrobial coating can extend along a length of the catheter to provide antimicrobial protection when the catheter is inserted into the patient's vasculature. The antimicrobial coating can also increase the effective diameter of the catheter to minimize the likelihood that the catheter will become kinked. 1. A vascular access device comprising:a catheter adapter;a catheter that extends distally from the catheter adapter; andan antimicrobial coating applied to at least a portion of the catheter, the antimicrobial coating comprising a base material that releases one or more antimicrobial agents when the antimicrobial coating is inserted within a patient's skin, the base material providing kink resistance to the catheter.2. The vascular access device of claim 1 , wherein the antimicrobial coating is positioned adjacent the catheter adapter.3. The vascular access device of claim 1 , wherein the antimicrobial coating includes an increased diameter portion.4. The vascular access device of claim 3 , wherein the increased diameter portion is positioned adjacent the catheter adapter.5. The vascular access device of claim 4 , wherein the diameter of the increased diameter portion increases towards the catheter adapter.6. The vascular access device of claim 1 , wherein a distal end of the antimicrobial coating is positioned proximal to a distal end of the catheter.7. The vascular access device of claim 6 , wherein the distal end of the antimicrobial coating is positioned at a distance from the catheter adapter that is based on an intended length of the catheter that should exist between an intimal layer of a vein and the catheter adapter when the catheter is inserted intravenously.8. The vascular access device of claim 1 , wherein the length of the antimicrobial coating is between 7 mm and 12 mm.9. The vascular access device of claim 1 , wherein the base material is ...

Подробнее
14-01-2016 дата публикации

Pharmaceutical compositions and devices for treatment of proliferative diseases

Номер: US20160008518A1
Автор: Thomas Q. Dinh
Принадлежит: Individual

A balloon catheter for delivering a combination of pharmaceutical active agents to a diseased blood vessel or conduit comprising an exterior coating layer of hydrophobic drugs with a first therapeutic agent is an mTor inhibitor and a second is an NF-kβ inhibitor. The pharmaceutical composition for treating proliferative diseases is further comprised of a mixture of two hydrophobic therapeutic agents coated on a medical device, with a first therapeutic agent is an mTor inhibitor and the second therapeutic agent is an NF-kβ inhibitor. The device and pharmaceutical combination comprise a method for treating proliferative diseases.

Подробнее
11-01-2018 дата публикации

CATHETER WITH MICRO-PELTIER COOLING COMPONENTS

Номер: US20180008332A1
Автор: Sheth Piyush
Принадлежит:

A catheter has a cooling distal section for freezing tissue to sub-zero temperatures with one or more miniature reverse thermoelectric or Peltier elements, also referred to herein as micro-Peltier cooling (MPC) units or electrodes. The MPC units may be on outer surface of an inflatable or balloon member or a tip electrode shell wall that has a fluid-containing interior cavity acting as a heat sink. Each MPC unit has a hot junction and a cold junction whose temperatures are regulated by the heat sink, and a voltage/current applied to the MPC units. A temperature differential of about 70 degrees Celsius may be achieved between the hot and cold junctions for extreme cooling, especially where the MPC units include semiconductor materials with high Peltier co-efficients. An outer coating of thermally-conductive but electrically-insulative material seals the MPC units to prevent unintended current paths through the MPC units. 2. The catheter of claim 1 , wherein the current flows from a first N-type semiconductor to a last P-type semiconductor.3. The catheter of claim 1 , wherein the distal section includes an inflatable balloon member having a membrane defining the interior cavity claim 1 , at least a portion of the membrane forming the substrate.4. The catheter of claim 1 , wherein the distal section includes a distal tip shell having a shell wall defining the interior cavity claim 1 , at least a portion of the shell wall forming the substrate.5. The catheter of claim 1 , wherein the cold junction includes an electrically-conductive material claim 1 , preceded by an N-type semiconductor material claim 1 , and followed by a P-type semiconductor material claim 1 , connected in series.6. The catheter of claim 1 , wherein the hot junction includes an electrically-conductive material claim 1 , preceded by P-type semiconductor material claim 1 , and followed by an N-type semiconductor material claim 1 , connected in series.7. The catheter of claim 1 , wherein the P-type ...

Подробнее